Processing 00000000.tx.1: The c-Abl Tyrosine Kinase Phosphorylates the Fe65 Adaptor Protein to Stimulate Fe65/Amyloid Precursor Protein Nuclear Signaling* Michael S. 

Phrase: "The c-Abl Tyrosine Kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1439337:ABL Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Phosphorylates"

Phrase: "the Fe65 Adaptor Protein to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Stimulate"

Phrase: "Fe65/Amyloid Precursor Protein Nuclear Signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]

Phrase: "* Michael S."
Processing 00000000.tx.2: Perkinton, Claire L. 

Phrase: "Perkinton,"

Phrase: "Claire L."
Processing 00000000.tx.3: Standen, Kwok-Fai Lau, Sashi Kesavapany, Helen L. 

Phrase: "Standen,"

Phrase: "Kwok-Fai Lau,"

Phrase: "Sashi Kesavapany,"

Phrase: "Helen L."
Processing 00000000.tx.4: Byers, Malcolm Ward, Declan M. 

Phrase: "Byers,"

Phrase: "Malcolm Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1305702:Ward [Health Care Related Organization,Manufactured Object]
   861   C1547134:Ward [Idea or Concept]
   861   C2355574:Ward [Population Group]

Phrase: "Declan M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: McLoughlin, and Christopher C. 

Phrase: "McLoughlin,"

Phrase: "and"

Phrase: "Christopher C."
Processing 00000000.tx.6: J. 

Phrase: "J."
Processing 00000000.tx.7: Miller|| From the Department of Neuroscience, the Section of Old Age Psychiatry, and Proteome Sciences plc, The Institute of Psychiatry, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom Received for publication, October 20, 2003 , and in revised form, February 16, 2004.  

Phrase: "Miller||"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "From the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "the Section of Old Age Psychiatry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205155:Section [Spatial Concept]
   753   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   753   C1522472:Section [Substance]
   753   C1552923:Section [Quantitative Concept]
   753   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "Proteome Sciences plc,"

Phrase: "The Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "King's College London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023973:London [Geographic Area]

Phrase: "De Crespigny Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "Denmark Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "London SE5 8AF,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 20,"

Phrase: "2003 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "February 16,"

Phrase: "2004."
Processing 00000000.tx.8: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The amyloid precursor protein (APP) is proteolytically processed to release a C-terminal domain that signals to the nucleus to regulate transcription of responsive genes. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "proteolytically"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a C-terminal domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "that signals to the nucleus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "regulate"

Phrase: "transcription of responsive genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0040649:genes transcription [Genetic Function]
           Transcription
Processing 00000000.tx.9: The APP C terminus binds to a number of phosphotyrosine binding (PTB) domain proteins and one of these, Fe65, stimulates APP nuclear signaling. 

Phrase: "The APP C terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "binds to a number of phosphotyrosine binding (PTB) domain proteins"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   790   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   773   C1514535:Protein Binding Domain [Amino Acid Sequence]
   764   C1323325:phosphotyrosine binding [Molecular Function]
   762   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745 E C0033618:Protein Binding [Molecular Function]
   745   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   745   C0162808:Protein Domain [Spatial Concept]
   745   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0237753:*Number [Quantitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1145667:Bind [Activity]
           Binding
   742   C1167622:Binding [Molecular Function]
           bind
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "one of these,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "stimulates"

Phrase: "APP nuclear signaling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.10: Fe65 is an adaptor protein that contains a number of protein-protein interaction domains. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "an adaptor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a number of protein-protein interaction domains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.11: These include two PTB domains, the second of which binds APP, and a WW domain that binds proline-rich ligands. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "two PTB domains,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   912   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "the second of which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205436:Second [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "a WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1861696:WW [Disease or Syndrome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "proline-rich ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligands [Chemical]
Processing 00000000.tx.12: One ligand for the Fe65WW domain is the tyrosine kinase c-Abl. 

Phrase: "One ligand for the Fe65WW domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023688:Ligand [Chemical]

Phrase: "is"

Phrase: "the tyrosine kinase c-Abl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704928:ABL [Gene or Genome]
Processing 00000000.tx.13: Here, we show that active c-Abl stimulates APP/Fe65-mediated gene transcription and that this effect is mediated by phosphorylation of Fe65 on tyrosine 547 within its second PTB domain. 

Phrase: "Here,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that active c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "stimulates"

Phrase: "APP/Fe65-mediated gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated by phosphorylation of Fe65"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1412459:FE65 [Gene or Genome]

Phrase: "on tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "within its second PTB domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.14: The homologous tyrosine within the motif Tyr-(Leu/Met)-Gly is conserved in a variety of PTB domains, and this suggests that PTB tyrosine phosphorylation occurs in other proteins. 

Phrase: "The homologous tyrosine within the motif Tyr-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Leu/Met)-Gly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0125601:Leu-Gly [Amino Acid, Peptide, or Protein]
   901   C0387019:Met-Gly [Amino Acid, Peptide, or Protein]
   827   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C0639683:Leu-Met [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "conserved in a variety of PTB domains,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   789   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   770   C1323325:phosphotyrosine binding [Molecular Function]
   744   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "this"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PTB tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1519726:Tyrosine Phosphorylation [Molecular Function]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurs in other proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.15: As such, PTB domain phosphorylation may represent a novel mechanism for regulating the function of this class of protein.  

Phrase: "As"

Phrase: "such,"

Phrase: "PTB domain phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]
   756   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a novel mechanism for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "the function of this class of protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0815043:function protein [Amino Acid, Peptide, or Protein]
   774   C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
Processing 00000000.tx.16: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The amyloid precursor protein (APP)1 is a type-1 membrane protein with a large ectodomain and a smaller C-terminal intracellular domain. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "is"

Phrase: "a type-1 membrane protein with a large ectodomain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0025255:Membrane [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "a smaller C-terminal intracellular domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.17: APP undergoes proteolytic processing by enzymes termed secretases. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "undergoes"

Phrase: "proteolytic processing by enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1514570:Proteolytic Processing [Molecular Function]
   770   C1709694:Processing [Activity]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "secretases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.18: ,-Secretases cleave at sites that are N-terminal to the membrane-spanning domain, and subsequently -secretase cleaves APP within the membrane. 

Phrase: ",-Secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleave at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205145:Sites [Spatial Concept]
   756 E C1515974:Site [Body Location or Region]
   756 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "N-terminal to the membrane-spanning domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "subsequently -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "APP within the membrane."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.19: The results of these activities are secreted products that include the large APP extracellular domain, the 4042-amino acid residue A peptide that is deposited in the brains of patients with Alzheimer's disease, and the remaining intracellular APP C-terminal domain (1). 

Phrase: "The results of these activities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the large APP extracellular domain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0162808:Protein Domain [Spatial Concept]
   839   C1514562:Protein Domain [Amino Acid Sequence]
   827   C1517050:Extracellular Domain [Spatial Concept]
   799   C0521119:Extracellular [Cell Component]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "the 4042-amino acid residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1709915:Residue [Conceptual Entity]
   812   C1882936:RESIDUE [Phenomenon or Process]
   741 E C1609982:Residual [Qualitative Concept]

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "is"

Phrase: "deposited in the brains of patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0333562:deposited [Functional Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the remaining intracellular APP C-terminal domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   836   C0162808:Protein Domain [Spatial Concept]
   836   C1514562:Protein Domain [Amino Acid Sequence]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: This C-terminal fragment contains a YENPTY motif and through this, APP binds to a number of phosphotyrosine binding (PTB) domain proteins. 

Phrase: "This C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a YENPTY motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "and through this,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "binds to a number of phosphotyrosine binding"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1323325:phosphotyrosine binding [Molecular Function]
   748   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0237753:*Number [Quantitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1145667:Bind [Activity]
           Binding
   748   C1167622:Binding [Molecular Function]
           bind

Phrase: "(PTB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1323325:phosphotyrosine binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "domain proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.21: These include the Fe65s, X11s (also known as munc-18-interacting proteins, mints), c-Jun N-terminal kinase (JNK)-interacting protein-1 (JIP-1), Numb, ShcA, and disabled (216). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the Fe65s,"

Phrase: "X11s"

Phrase: "(also"

Phrase: "known as munc-18-interacting proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0649046:Munc-18 Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0054966:Protein 18 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205309:Known [Qualitative Concept]

Phrase: "mints"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0522467:mints [Plant]
   966 E C0452249:Mint [Food]
   966 E C1337213:mint [Food]
   966 E C1576800:MINT [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(JNK)-interacting protein-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1417024:JNK-INTERACTING PROTEIN 1 [Gene or Genome]
   923   C1422725:JNK interacting protein [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "(JIP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417024:JIP-1 [Gene or Genome]
   861   C0345893:JIP [Neoplastic Process]

Phrase: ")"

Phrase: ","

Phrase: "Numb,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417890:NUMB [Gene or Genome]
  1000   C1709287:Numb [Individual Behavior]

Phrase: "ShcA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1312062:SHCA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335821:SHCA [Gene or Genome]
  1000   C1705297:SHCA [Gene or Genome]

Phrase: "and"

Phrase: "disabled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018576:Disabled [Patient or Disabled Group]
  1000   C1880351:Disabled [Qualitative Concept]

Phrase: "(216"

Phrase: ")."
Processing 00000000.tx.22: The functions of APP are not properly understood, although recently its proteolytically processed C-terminal domain has been shown to translocate to the nucleus to regulate transcription (1724). 

Phrase: "The functions of APP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "not properly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "although"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "its proteolytically processed C-terminal domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "translocate to the nucleus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007610:Nucleus [Cell Component]

Phrase: "regulate"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "(1724"

Phrase: ")."
Processing 00000000.tx.23: To do so, it complexes with a number of nuclear proteins, one of which is the adaptor protein Fe65. 

Phrase: "To do so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883351:To [Qualitative Concept]

Phrase: "it complexes with a number of nuclear proteins,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   750   C1880155:Complex Number [Quantitative Concept]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   734   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1523872:protein complex [Cell Component]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the adaptor protein Fe65."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412459:FE65 [Gene or Genome]
   734   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.24: Fe65 contains a variety of protein-protein interaction domains including two C-terminal PTB domains (the second of which binds APP) and a WW domain that interacts with proline-rich ligands. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a variety of protein-protein interaction domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "two C-terminal PTB domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   850   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   766   C1880389:Domain [Functional Concept]
   766   C1883221:Domain [Conceptual Entity]
   766   C3541951:Domain [Intellectual Product]
   700   C1149341:C-terminal binding [Molecular Function]

Phrase: "("

Phrase: "the second of which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205436:Second [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1861696:WW [Disease or Syndrome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "interacts with proline-rich ligands."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023688:Ligands [Chemical]
   760   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0699759:Rich [Qualitative Concept]
Processing 00000000.tx.25: The first Fe65 PTB domain binds to two transcription factors, the histone acetyltransferase Tip60 and CP2/LSF/LBP1, and Tip60 stimulates APP/Fe65 transcriptional activity (19, 25). 

Phrase: "The first Fe65 PTB domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "binds to two transcription factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040649:Transcription [Genetic Function]
   760   C0205448:Two [Quantitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "the histone acetyltransferase Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]
   734   C0062773:histone acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "CP2/LSF/LBP1,"

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "stimulates"

Phrase: "APP/Fe65 transcriptional activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   898   C1325278:amyloid protein activity [Molecular Function]
   858   C1537044:protein activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "(19,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.26: The full complement of binding partners for the Fe65WW domain are not known, but include the mammalian homologue of Drosophila enabled (Mena) and the c-Abl tyrosine kinase (26, 27). 

Phrase: "The full complement of binding partners"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1523308:complement binding [Molecular Function]
   753   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "for the Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the mammalian homologue of Drosophila"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologue [Gene or Genome]

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "(Mena"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the c-Abl tyrosine kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1439337:ABL Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.27: The molecular mechanisms that control APP/Fe65 nuclear signaling are not properly understood and indeed, APP can function to inhibit Fe65 nuclear translocation (28). 

Phrase: "The molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "APP/Fe65 nuclear signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]

Phrase: "are"

Phrase: "not properly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "and"

Phrase: "indeed,"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Fe65 nuclear translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518440:Nuclear Translocation [Molecular Function]
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.28: However, the Fe65WW domain is required for potent APP/Fe65-mediated transcription and also for nuclear translocation of Fe65 (19, 28). 

Phrase: "However,"

Phrase: "the Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for potent APP/Fe65-mediated transcription"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040649:Transcription [Genetic Function]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1412459:FE65 [Gene or Genome]
   742   C1514873:Required [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "also for nuclear translocation of Fe65"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1518440:Nuclear Translocation [Molecular Function]
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1412459:FE65 [Gene or Genome]
   753   C2987521:Translocation [Activity]

Phrase: "(19,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.29: This suggests that its binding partners may contribute to the transcriptional competency of the complex. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "its binding partners"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C0682323:partners [Family Group]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "may"

Phrase: "contribute to the transcriptional competency of the complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0040649:Transcriptional [Genetic Function]
   744   C0086035:Competency [Qualitative Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1880177:Contribute [Activity]
Processing 00000000.tx.30: One partner, c-Abl, is known to be present within the nucleus (29, 30) and has been shown to phosphorylate APP on tyrosine 682 (27). 

Phrase: "One partner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0682323:Partner [Family Group]

Phrase: "c-Abl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present within the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "APP on tyrosine 682"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.31: Here, we demonstrate that active c-Abl also phosphorylates Fe65 and that this phosphorylation functions to stimulate APP/Fe65 transcriptional activity.  

Phrase: "Here,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that active c-Abl also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704928:ABL [Gene or Genome]

Phrase: "phosphorylates"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "this phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "APP/Fe65 transcriptional activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   898   C1325278:amyloid protein activity [Molecular Function]
   858   C1537044:protein activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.32: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Experiments involving immunoprecipitation, glutathione S-transferase (GST) pull-downs, and GSK3 labeling were all performed at least three times with similar results. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "glutathione S-transferase (GST) pull-downs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0580846:pull [Finding]
   733   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   733   C2626739:Lanugo [Eukaryote]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GSK3 labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "all"

Phrase: "performed at least three times"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.33: Reporter gene transcription assays were repeated as indicated in the text. 

Phrase: "Reporter gene transcription assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040649:Gene Transcription [Genetic Function]
           Transcription
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "as"

Phrase: "indicated in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1444656:Indicated [Finding]
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.34: Cell Culture, Transfection, and Indirect ImmunofluorescenceCHO and COS-7 cells were grown in F-12(HAM) or Dulbecco's modified Eagle's medium, respectively, containing 10% (v/v) fetal bovine serum supplemented with 2 mM glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin (Invitrogen). 

Phrase: "Cell Culture,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "Transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Indirect ImmunofluorescenceCHO"

Phrase: "and"

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in F-12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0439133:(f) [Intellectual Product]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "(HAM)"

Phrase: "or"

Phrase: "Dulbecco's modified Eagle's medium,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "respectively,"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10%"

Phrase: "(v/v) fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0007452:Bovine [Mammal]
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0521457:Fetal [Functional Concept]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "supplemented with 2 mM glutamine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "100 units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100 g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.35: Cells were transfected using LipofectAMINE (Invitrogen) according to the manufacturer's instructions. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.36: For immunofluorescence staining, cells were grown and transfected on glass coverslips, and then fixed and processed for immunocytochemistry as described (31). 

Phrase: "For immunofluorescence staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "and"

Phrase: "transfected on glass coverslips,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "processed for immunocytochemistry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0242349:Immunocytochemistry [Laboratory Procedure]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.37: Captured images were analyzed for fluorescent signal intensity using Metamorph image analysis software. 

Phrase: "Captured images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "analyzed for fluorescent signal intensity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0871362:signal intensity [Quantitative Concept]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0522510:Intensity [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Metamorph image analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.38: Plasmids and MutagenesisPlasmids for expression of wild-type and C-terminal Myc-tagged Fe65 and for the APP695 isoform were as described (32). 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "MutagenesisPlasmids for expression of wild-type"

Phrase: "and"

Phrase: "C-terminal Myc-tagged Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1412459:FE65 [Gene or Genome]

Phrase: "and for the APP695 isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   760   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.39: Tyrosines 117, 234, 269, 270, 403, 467, 546, 547, and 658 in Fe65 were mutated to phenylalanine using the QuikChange mutagenesis kit (Stratagene) according to the manufacturer's instructions. 

Phrase: "Tyrosines 117,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "234,"

Phrase: "269,"

Phrase: "270,"

Phrase: "403,"

Phrase: "467,"

Phrase: "546,"

Phrase: "547,"

Phrase: "and"

Phrase: "658 in Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412459:FE65 [Gene or Genome]

Phrase: "were"

Phrase: "mutated to phenylalanine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QuikChange mutagenesis kit (Stratagene"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.40: Mutagenic oligonucleotides were: Y117F, 5'-GGCCTGATACACCTGTTCTCTGAGCTGGAGCTC-3' and 5'-GAGCTCCAGCTCAGAGAACAGGTGTATCAGGCC-3'; 

Phrase: "Mutagenic oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: ":"

Phrase: "Y117F,"

Phrase: "5'-GGCCTGATACACCTGTTCTCTGAGCTGGAGCTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GAGCTCCAGCTCAGAGAACAGGTGTATCAGGCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.41: Y234F, 5'-CAGGGCAGCCCCTCCTTTGGCTCCCCAGAGGAC-3' and 5'-GTCCTCTGGGGAGCCAAAGGAGGGGCTGCCCTG-3'; 

Phrase: "Y234F,"

Phrase: "5'-CAGGGCAGCCCCTCCTTTGGCTCCCCAGAGGAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GTCCTCTGGGGAGCCAAAGGAGGGGCTGCCCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.42: Y269F, 5'-GGACACCTCAGGGACCTTTTACTGGCACATCCCAACAGGG-3' and 5'-CCCTGTTGGGATGTGCCAGTAAAAGGTCCCTGAGGTGTCC-3'; 

Phrase: "Y269F,"

Phrase: "5'-GGACACCTCAGGGACCTTTTACTGGCACATCCCAACAGGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CCCTGTTGGGATGTGCCAGTAAAAGGTCCCTGAGGTGTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.43: Y270F, 5'-GGACACCTCAGGGACCTATTTCTGGCACATCCCAACAGGG-3' and 5'-CCCTGTTGGGATGTGCCAGAAATAGGTCCCTGAGGTGTCC-3'; 

Phrase: "Y270F,"

Phrase: "5'-GGACACCTCAGGGACCTATTTCTGGCACATCCCAACAGGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CCCTGTTGGGATGTGCCAGAAATAGGTCCCTGAGGTGTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.44: Y403F, 5'-CATCCGTCAGCTCTCTTTCCACAAAAACAACCTG-3' and 5'-CAGGTTGTTTTTGTGGAAAGAGAGCTGACGGATG-3'; 

Phrase: "Y403F,"

Phrase: "5'-CATCCGTCAGCTCTCTTTCCACAAAAACAACCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CAGGTTGTTTTTGTGGAAAGAGAGCTGACGGATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.45: Y467F, 5'-GAGAGGGACTTTGCCTTCGTAGCTCGTGATAAG-3' and 5'-CTTATCACGAGCTACGAAGGCAAAGTCCCTCTC-3'; 

Phrase: "Y467F,"

Phrase: "5'-GAGAGGGACTTTGCCTTCGTAGCTCGTGATAAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CTTATCACGAGCTACGAAGGCAAAGTCCCTCTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.46: Y546F, 5'-CAGAAGTTCCAAGTCTTTTACCTGGGGAATGTACCTG-3' and 5'-CAGGTACATTCCCCAGGTAAAAGACTTGGAACTTCTG-3'; 

Phrase: "Y546F,"

Phrase: "5'-CAGAAGTTCCAAGTCTTTTACCTGGGGAATGTACCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CAGGTACATTCCCCAGGTAAAAGACTTGGAACTTCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.47: Y547F, 5'-CAGAAGTTCCAAGTCTATTTCCTGGGGAATGTACCTG-3' and 5'-CAGGTACATTCCCCAGGAAATAGACTTGGAACTTCTG-3'; 

Phrase: "Y547F,"

Phrase: "5'-CAGAAGTTCCAAGTCTATTTCCTGGGGAATGTACCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CAGGTACATTCCCCAGGAAATAGACTTGGAACTTCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.48: Y658F, 5'-GCGTGCATGCTTCGCTTCCAGAAGTGTCTGGATG-3' and 5'-CATCCAGACACTTCTGGAAGCGAAGCATGCACGC-3'. 

Phrase: "Y658F,"

Phrase: "5'-GCGTGCATGCTTCGCTTCCAGAAGTGTCTGGATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CATCCAGACACTTCTGGAAGCGAAGCATGCACGC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.49: Tyrosine 682 in APP was mutated to phenylalanine in a similar fashion using oligonucleotides 5'-GATGCAGCAGAACGGCTTCGAAAATCCAACCTACAAGTTC-3' and 5'-GAACTTGTAGGTTGGATTTTCGAAGCCGTTCTGCTGCATC-3'. 

Phrase: "Tyrosine 682 in APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "mutated to phenylalanine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "in a similar fashion"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotides 5'-GATGCAGCAGAACGGCTTCGAAAATCCAACCTACAAGTTC-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-GAACTTGTAGGTTGGATTTTCGAAGCCGTTCTGCTGCATC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.50: Expression plasmids for c-Abl and an active isoform of c-Abl in which the N-terminal autoinhibitory domain is deleted (c-AblXB) in pCDNA3 were as described (33). 

Phrase: "Expression plasmids for c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "an active isoform of c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "in which"

Phrase: "the N-terminal autoinhibitory domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(c-AblXB"

Phrase: ")"

Phrase: "in pCDNA3"

Phrase: "were"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.51: GST fusion proteins containing the Fe65WW domain and the Fe65PTB2 domain were created by amplifying the appropriate sequences by PCR using Pfu polymerase and cloning the products into pGEX-5X-2 and pGEX-5X-1 as EcoR1-SalI and SalI fragments, respectively. 

Phrase: "GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the Fe65PTB2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "created by amplifying"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the appropriate sequences by PCR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Pfu polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0136227:Pfu polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "the products into pGEX-5X-2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "pGEX-5X-1 as EcoR1-SalI"

Phrase: "and"

Phrase: "SalI fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.52: Primers used were: 5'-GCGGAATTCAACCCCAACGCCTTCGAGACGGAT-3' and 5-CGCGTCGACCTATGAGGGGGAGGCCCGGCCGGGGGGTTCCCACTGGGTGGTCCC-3' (Fe65WW domain) and 5'-GCGGTCGACTCCAAGTGGAATTCCCAGCGC-3' and 5-GCGGTCGACTCATGGGGTATGGGCCCCCAG-3' (Fe65PTB2 domain). 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: ":"

Phrase: "5'-GCGGAATTCAACCCCAACGCCTTCGAGACGGAT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5-CGCGTCGACCTATGAGGGGGAGGCCCGGCCGGGGGGTTCCCACTGGGTGGTCCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "5'-GCGGTCGACTCCAAGTGGAATTCCCAGCGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5-GCGGTCGACTCATGGGGTATGGGCCCCCAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(Fe65PTB2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: Residues Tyr-Tyr-Trp within the Fe65WW domain were mutated to Ala-Ala-Ala as described above using oligonucleotides 5'-GGACACCTCAGGGACCGCTGCCGCGCACATCCCAACAGGG-3' and 5'-CCCTGTTGGGATGTGCGCGGCAGCGGTCCCTGAGGTGTCC-3'. 

Phrase: "Residues Tyr-Tyr-Trp within the Fe65WW domain"

Phrase: "were"

Phrase: "mutated to Ala-Ala-Ala"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   862   C0051069:Ala-Ala-Ala [Amino Acid, Peptide, or Protein]
   806   C0051078:Ala-Ala [Amino Acid, Peptide, or Protein]
   760   C1705285:Mutated [Cell or Molecular Dysfunction]
   726 E C1513776:Mutate [Genetic Function]

Phrase: "as"

Phrase: "described above"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotides 5'-GGACACCTCAGGGACCGCTGCCGCGCACATCCCAACAGGG-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-CCCTGTTGGGATGTGCGCGGCAGCGGTCCCTGAGGTGTCC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.54: GAL4UAS-dependent firefly luciferase reporter pFR-Luc and transfection efficiency Renilla luciferase phRL-TK plasmids were obtained from Stratagene and Promega, respectively. 

Phrase: "GAL4UAS-dependent firefly luciferase reporter pFR-Luc"

Phrase: "and"

Phrase: "transfection efficiency Renilla luciferase phRL-TK plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "obtained from Stratagene"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "respectively."
Processing 00000000.tx.55: Plasmid expressing the GAL4 DNA binding domain fused to the C-terminal 50 amino acids of APP (GAL4-APPc) and which corresponds to an in vivo fragment generated by / cleavage (3436) was created by subcloning APPc-encoding sequences into pM1 (37). 

Phrase: "Plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "the GAL4 DNA binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "fused to the C-terminal 50 amino acids of APP"
Meta Candidates (Total=26; Excluded=4; Pruned=0; Remaining=22)
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   767   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
           C-Terminal
   766   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C1168438:Protein C [Laboratory Procedure]
   751   C1418943:PROTEIN C [Gene or Genome]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0001128:Acids [Chemical]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205088:Terminal [Temporal Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0699952:Fused [Functional Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1709634:Precursor [Idea or Concept]
   719 E C2917660:Amino Acid [Pharmacologic Substance]
   703 E C0202406:Acid [Laboratory Procedure]
   703 E C1414861:FUSE [Gene or Genome]
   703 E C1708111:Fuse [Manufactured Object]

Phrase: "(GAL4-APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "which"

Phrase: "corresponds to an in vivo fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "generated by / cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
   790   C3146294:Generated [Activity]

Phrase: "(3436"

Phrase: ")"

Phrase: "was"

Phrase: "created by subcloning APPc-encoding sequences"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C1707531:Created By [Qualitative Concept]
   753   C0052145:APPC [Antibiotic,Organic Chemical]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C1547699:Encoding [Idea or Concept]
   753   C1706214:Created [Activity]
   753   C2700640:Encoding [Activity]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]
   719 E C3244320:create [Functional Concept]

Phrase: "into pM1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456957:pM1 [Finding]
  1000   C1823304:PM1 [Gene or Genome]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.56: Full-length APP into which the GAL4 DNA binding domain had been engineered (GAL4-APP) was as described (19). 

Phrase: "Full-length APP into which"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "the GAL4 DNA binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "had"

Phrase: "been"

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "(GAL4-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.57: Full-length APP containing the GAL4 DNA binding domain at its C terminus was created by mutating residue 148 of the GAL4 sequence to a stop codon in plasmid APP-GAL4 (kind gift of Tomasso Russo). 

Phrase: "Full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the GAL4 DNA binding domain at its C terminus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1511662:DNA Binding Domain [Amino Acid Sequence]
   764   C1148673:DNA Binding [Genetic Function]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "created by mutating residue 148 of the GAL4 sequence"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C1707531:Created By [Qualitative Concept]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1416832:GAL4 [Gene or Genome]
   742   C1519249:Sequence [Functional Concept]
   742   C1706214:Created [Activity]
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]
   708   C1513776:Mutate [Genetic Function]
   708 E C3244320:create [Functional Concept]

Phrase: "to a stop codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242611:Stop Codon [Nucleotide Sequence]
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "in plasmid APP-GAL4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1416832:GAL4 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(kind gift of Tomasso Russo"

Phrase: ")."
Processing 00000000.tx.58: Plasmid APP-GAL4 encodes a chimeric protein comprising full-length GAL4 fused to the C terminus of APP (38). 

Phrase: "Plasmid APP-GAL4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1416832:GAL4 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a chimeric protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162768:Chimeric Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "comprising"

Phrase: "full-length GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1416832:GAL4 [Gene or Genome]

Phrase: "fused to the C terminus of APP"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0699952:Fused [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
   708 E C1414861:FUSE [Gene or Genome]
   708 E C1708111:Fuse [Manufactured Object]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.59: Mutation of GAL4 residue 148 truncates the GAL4 sequence so that it contains only the DNA binding domain. 

Phrase: "Mutation of GAL4 residue 148"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "truncates"

Phrase: "the GAL4 sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "it"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the DNA binding domain."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511662:DNA Binding Domain [Amino Acid Sequence]
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.60: Mutagenic oligonucleotides were 5'-CTGTATCGATTGACTAGGCAGCTCATCATG-3' and 5'-CATGATGAGCTGCCTAGTCAATCGATACAG-3'. 

Phrase: "Mutagenic oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "5'-CTGTATCGATTGACTAGGCAGCTCATCATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CATGATGAGCTGCCTAGTCAATCGATACAG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.61: To express the C-terminal domain of APP, sequences encoding the last 50 residues of APP were cloned into the vector pCMV-Tag2 (Stratagene). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the C-terminal domain of APP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the last 50 residues of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "cloned into the vector pCMV-Tag2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.62: SDS-PAGE and ImmunoblottingSamples were processed for SDS-PAGE by addition of SDS-PAGE sample buffer and heating in a boiling water bath. 

Phrase: "SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "ImmunoblottingSamples"

Phrase: "were"

Phrase: "processed for SDS-PAGE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1522240:Processed [Phenomenon or Process]
   770   C1704732:Page [Intellectual Product]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "by addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of SDS-PAGE sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "heating in a boiling water bath."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018851:Heating [Environmental Effect of Humans]
Processing 00000000.tx.63: Samples were separated on either 8.5 or 12.5% (w/v) acrylamide gels and transferred to Protran nitrocellulose membranes (Schleicher & Schuell) using a Bio-Rad TransBlot system. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated on either 8.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "or"

Phrase: "12.5%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "acrylamide gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred to Protran nitrocellulose membranes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Schleicher & Schuell"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bio-Rad TransBlot system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.64: Following blocking and probing with primary antibodies, the blots were washed and incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse Ig (Amersham Biosciences) and developed using an enhanced chemiluminescence system (Amersham Biosciences) according to the manufacturer's instructions. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "probing with primary antibodies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0419358:Probing, NOS [Diagnostic Procedure]

Phrase: "the blots"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated with horseradish peroxidase-conjugated anti-rabbit"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0034493:Rabbit [Mammal]
   748   C0330510:Horseradish [Food]
   748   C0522529:Conjugated [Spatial Concept]
   748   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   748   C1110641:Horseradish [Plant]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "anti-mouse Ig (Amersham Biosciences"

Phrase: ")"

Phrase: "and"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enhanced chemiluminescence system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.65: The Fe65 and APP (APPab recognizing the C terminus of APP) antibodies have been described previously (32, 39, 40). 

Phrase: "The Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APPab"

Phrase: "recognizing"

Phrase: "the C terminus of APP"

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(32,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.66: Anti-Myc antibody 9B11 (that recognizes Myc-tagged Fe65) was obtained from Cell Signaling Technology, c-Abl antibody (2411) was from Santa Cruz Biotechnology, APP antibody 22C11 (recognizing the N terminus of APP) was from Roche Applied Science, phosphotyrosine antibody 4G10 was from Upstate Cell Signaling, anti-GSK3 was from BD Transduction Laboratories, and antibody DM1A to tubulin was from Sigma. 

Phrase: "Anti-Myc antibody 9B11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "("

Phrase: "that"

Phrase: "recognizes"

Phrase: "Myc-tagged Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412459:FE65 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Cell Signaling Technology,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   813   C1371607:Increased Cell Signaling [Cell Function]
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1706701:Obtain [Activity]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "c-Abl antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0368815:C ANTIBODY [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1963095:c Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0079050:c abl [Gene or Genome]
   734   C1412097:c-ABL [Gene or Genome]
   734   C1704928:c-Abl [Gene or Genome]

Phrase: "(2411"

Phrase: ")"

Phrase: "was from Santa Cruz Biotechnology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]

Phrase: "APP antibody 22C11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "("

Phrase: "recognizing"

Phrase: "the N terminus of APP"

Phrase: ")"

Phrase: "was from Roche Applied Science,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0681834:Applied Science [Research Activity]
   760   C0036397:Science [Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0185125:Applied [Health Care Activity]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0331965:Roche [Health Care Related Organization]
   760   C1421478:WAS [Gene or Genome]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "phosphotyrosine antibody 4G10"

Phrase: "was from Upstate Cell Signaling,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1269647:Cell [Cell]
   760   C1421478:WAS [Gene or Genome]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]

Phrase: "anti-GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was from BD Transduction Laboratories,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1160185:transduction [Organism Function]
   760   C1421478:WAS [Gene or Genome]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "antibody DM1A to tubulin"

Phrase: "was from Sigma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.67: Immunoprecipitation and GST Pull-down AssaysImmunoprecipitation and GST pull-down assays were performed as previously described (39, 41). 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "GST Pull-down AssaysImmunoprecipitation"

Phrase: "and"

Phrase: "GST pull-down assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(39,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.68: Briefly, for immunoprecipitation assays, cells were lysed in ice-cold lysis buffer comprising 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 0.5 mM sodium orthovanadate, 30 mM sodium fluoride, and protease inhibitors (Complete, Roche Applied Science) and then cleared by centrifugation at 14,000 x g for 30 min at 4 C. 

Phrase: "Briefly,"

Phrase: "for immunoprecipitation assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in ice-cold lysis buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0024348:Lysis [Pathologic Function]
           lysed
   753   C0234192:Cold [Physiologic Function]
   753   C1536403:lysis [Cell Function]

Phrase: "comprising"

Phrase: "50 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.5 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0029366:Orthovanadate [Inorganic Chemical]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "30 mM sodium fluoride,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037508:Sodium Fluoride [Biomedical or Dental Material,Inorganic Chemical]
   861   C1171560:sodium fluoride [Pharmacologic Substance]
   861   C1556062:Sodium Fluoride [Intellectual Product]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   805 E C0721463:Luride [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Complete, Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0681834:Applied Science [Research Activity]
   812   C0036397:Science [Occupation or Discipline]
   812   C0185125:Applied [Health Care Activity]
   779 E C1632850:Apply [Functional Concept]
   779 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cleared by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "at 14,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.69: Cell lysates were then precleared with either protein A- or protein G-Sepharose beads (Sigma) and the target protein immunoprecipitated. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "precleared with either protein A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "protein G-Sepharose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "the target protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "immunoprecipitated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.70: Following washing of the beads in lysis buffer, immunoprecipitated proteins were resolved by SDS-PAGE and detected by immunoblotting. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "washing of the beads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441648:Washing [Activity]

Phrase: "in lysis buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "immunoprecipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "detected by immunoblotting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.71: GST and GST-Fe65WW domain proteins expressed in Escherichia coli BL21(DE3) were prepared essentially according to the manufacturer's instructions (Amersham Biosciences). 

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GST-Fe65WW domain proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in Escherichia coli BL21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014834:Escherichia coli [Bacterium]
   760   C0014833:Escherichia [Bacterium]
   760   C0450615:BL21 [Body Location or Region]

Phrase: "(DE3"

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "essentially according to the manufacturer's instructions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.72: Equimolar amounts of GST or GST-Fe65WW domain baits were used in pull-down assays from transfected cell lysates. 

Phrase: "Equimolar amounts of GST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "or"

Phrase: "GST-Fe65WW domain baits"

Phrase: "were"

Phrase: "used in pull-down assays"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0580846:pull [Finding]
   760   C1273517:used [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "from transfected cell lysates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.73: Cell lysates were prepared by harvesting cells into lysis buffer as described above. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "prepared by harvesting cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1512335:Harvest [Health Care Activity]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "into lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "as described above."
Processing 00000000.tx.74: Captured proteins were then isolated by boiling in SDS-PAGE sample buffer and analyzed by SDS-PAGE and immunoblotting. 

Phrase: "Captured proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "isolated by boiling"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756   C0242301:Boil [Disease or Syndrome]
   756 E C0370215:Isolate [Substance]
   756   C1546559:Boil [Intellectual Product]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in SDS-PAGE sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.75: Mass Spectrometric Sequencing of Fe65Fe65 was sequenced by on-line liquid chromatography tandem mass spectrometry (LC/MS/MS) as recently described by us (42). 

Phrase: "Mass Spectrometric Sequencing of Fe65Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "sequenced by on-line liquid chromatography tandem mass spectrometry (LC/MS/MS)"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   807   C0872318:Liquid Chromatography Mass Spectrometry [Laboratory Procedure]
   790   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   764   C0008565:Liquid Chromatography [Laboratory Procedure]
   764   C0037813:Mass Spectrometry [Laboratory Procedure]
   762   C2945612:chromatography mass [Laboratory Procedure]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   742   C0205132:Line [Spatial Concept]
   742   C0302908:Liquid [Substance]
   742   C0436196:Spectrometry [Laboratory Procedure]
   742   C0577559:Mass [Finding]
   742   C1304698:Liquid [Finding]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1546699:Liquid NOS [Intellectual Product]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C1561501:Liquid NOS [Substance]
   742   C3152252:Mass [Quantitative Concept]
   708   C0004793:Sequence [Nucleotide Sequence]
   708   C0162326:Sequence [Nucleotide Sequence]
   708   C0162327:Sequence [Nucleotide Sequence]
   708   C1519249:Sequence [Functional Concept]

Phrase: "as"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "described by us (42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.76: Briefly, Fe65 was isolated by immunoprecipitation from Fe65 and Fe65+c-AblXB-co-transfected cells using antibody 9B11 to the Myc tag on Fe65 and resolved by SDS-PAGE. 

Phrase: "Briefly,"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "isolated by immunoprecipitation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Fe65+c-AblXB-"

Phrase: "co-transfected"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 9B11 to the Myc tag"

Phrase: "on Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "resolved by SDS-PAGE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.77: The bands corresponding to Fe65 were excised, reduced, alkylated, and digested with either trypsin, Asp-N, Lys-C, or chymotrypsin (Roche Applied Science) and extracted from the gel pieces with two wash cycles of 50 mM NH4HCO3 and acetonitrile, lyophilized, and resuspended in 20 l of 50 mM NH4HCO3. 

Phrase: "The bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "corresponding to Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412459:FE65 [Gene or Genome]

Phrase: "were"

Phrase: "excised"

Phrase: ","

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "alkylated"

Phrase: ","

Phrase: "and"

Phrase: "digested with either trypsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0868946:digested [Physiologic Function]

Phrase: "Asp-N,"

Phrase: "Lys-C,"

Phrase: "or"

Phrase: "chymotrypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "extracted from the gel pieces"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1382104:Gel [Substance]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
   726   C2982836:Piece [Quantitative Concept]

Phrase: "with two wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Wash [Activity]

Phrase: "cycles of 50 mM NH4HCO3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "acetonitrile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "lyophilized"

Phrase: ","

Phrase: "and"

Phrase: "resuspended in 20 l of 50 mM NH4HCO3."
Processing 00000000.tx.78: Chromatographic separations were performed using an Ultimate LC system (Dionex). 

Phrase: "Chromatographic separations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0237868:Separations [Social Behavior]
   827 E C0036679:Separation [Pathologic Function]
   827 E C1881713:SEPARATION [Phenomenon or Process]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Ultimate LC system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Dionex"

Phrase: ")."
Processing 00000000.tx.79: Peptides were ionized by electrospray ionization using a Z-spray source fitted to a QTof-micro (Micromass). 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "ionized by electrospray ionization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1516801:Electrospray Ionization [Laboratory Procedure]
   770   C0596801:Ionization [Phenomenon or Process]
   770   C1979910:Ionized [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Z-spray source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449416:Source [Finding]
   827   C1705919:Source [Idea or Concept]

Phrase: "fitted to a QTof-micro"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036572:Fit [Sign or Symptom]
   760   C0085672:MICRO [Laboratory Procedure]
   760   C0424576:Fit [Finding]
   760   C1553035:Micro [Quantitative Concept]
   760   C2349186:Fit [Activity]

Phrase: "(Micromass"

Phrase: ")."
Processing 00000000.tx.80: The instrument was set to run in automated switching mode, selecting precursor ions based on their intensity and charge state, for sequencing by collision-induced fragmentation. 

Phrase: "The instrument"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0348000:Instrument [Medical Device]

Phrase: "was"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to run in"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C3274438:RUN-IN [Temporal Concept]
   827   C0035953:run [Daily or Recreational Activity]
   827   C0600140:run [Finding]
   827   C1704688:Run [Functional Concept]
   827   C2346414:Run [Finding]

Phrase: "automated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205554:Automated [Functional Concept]
   928 E C0004376:Automation [Machine Activity]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "mode,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1513371:Mode [Functional Concept]
  1000   C1705738:Mode [Quantitative Concept]
  1000   C2347637:Mode [Quantitative Concept]
  1000   C2348146:Mode [Quantitative Concept]

Phrase: "selecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "precursor ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "based on their intensity"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0522510:Intensity [Qualitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "charge state,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "for sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "by collision-induced fragmentation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332472:Fragmentation [Anatomical Abnormality]
   827   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.81: The MS/MS analyses were conducted using collision energy profiles that were chosen based on the mass/charge (m/z) and the charge state of the peptide and optimized for phosphorylated peptides. 

Phrase: "The MS/MS analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0599748:MS/MS [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "collision energy profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "based on the mass/charge"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007961:Charge [Quantitative Concept]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1706211:Charge [Organism Attribute]
   760   C3152252:Mass [Quantitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(m/z)"

Phrase: "and"

Phrase: "the charge state of the peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "optimized for phosphorylated peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1519061:Phosphorylated Peptide [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.82: The mass spectral data were processed into peak lists containing the m/z value of each precursor ion and the corresponding fragment ion m/z values and intensities. 

Phrase: "The mass spectral data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "processed into peak lists"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0444505:Peak [Quantitative Concept]
   770   C1522240:Processed [Phenomenon or Process]
   737   C0745732:List [Conceptual Entity]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
   737   C3272378:LIST [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the m/z value of each precursor ion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the corresponding fragment ion m/z values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0042295:Values [Qualitative Concept]
   766 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "intensities."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:intensities [Qualitative Concept]
Processing 00000000.tx.83: Data were searched against a custom built data base containing the full-length sequence of Fe65 using the Mascot searching algorithm (Matrix Science). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "searched against a custom built data base"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0242356:Database [Intellectual Product]
   778   C0993637:Data Base [Intellectual Product]
   748   C0002055:base [Inorganic Chemical]
   748   C0162343:Custom [Idea or Concept]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C1511726:Data [Idea or Concept]
   748   C1706202:Searched [Activity]
   748   C1880202:Custom [Activity]
   748   C1880279:Base [Biomedical or Dental Material]
   748   C3245479:data [Medical Device]
   714 E C1552603:search [Intellectual Product]
   714   C1707059:Build [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the full-length sequence of Fe65"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Mascot searching algorithm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002045:algorithm [Intellectual Product]
   827   C1553907:algorithm [Laboratory Procedure]

Phrase: "(Matrix Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.84: Peptides and phosphopeptides of Fe65 were identified by matching the MS/MS data against mass values generated from the theoretical fragmentation of peptides based on the search criteria set (i.e. the cleavage enzyme used with up to 3 missed cleavages, carbamidomethyl modification of cysteine residues, oxidized methionine, deamidation of asparagine and glutamine residues, and N-acetylation of the protein). 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "phosphopeptides of Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0031684:Phosphopeptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "identified by matching"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0150103:MATCHING [Research Activity]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1708943:Matching [Qualitative Concept]

Phrase: "the MS/MS data against mass values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1704610:Data Value [Intellectual Product]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "generated from the theoretical fragmentation of peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0332472:Fragmentation [Anatomical Abnormality]
   748   C0871935:Theoretical [Idea or Concept]
   748   C1881708:FRAGMENTATION [Phenomenon or Process]
   748   C3146294:Generated [Activity]

Phrase: "based on the search criteria set (i.e."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   770   C1710036:Search Criteria [Conceptual Entity]
   744   C0021966:I- [Inorganic Chemical]
   744   C0036849:Set [Mental Process]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0243161:criteria [Intellectual Product]
   744   C1442518:Set [Functional Concept]
   744   C1527178:Based [Functional Concept]
   744   C1552603:search [Intellectual Product]
   744   C1705195:Set [Conceptual Entity]
   744   C1705938:Based [Idea or Concept]
   744   C1706202:Search [Activity]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the cleavage enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "used with"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "up to 3 missed cleavages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0010813:cleavage [Cell Function]
   793   C0596311:Cleavage [Phenomenon or Process]
   793   C1330957:cleavage [Cell Function]

Phrase: "carbamidomethyl modification of cysteine residues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "oxidized methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "deamidation of asparagine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0872015:deamidation [Phenomenon or Process]
   790   C1330964:Deamidation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "glutamine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "N-acetylation of the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1521754:Protein Acetylation [Molecular Function]
           Acetylation
   760   C0001038:Acetylation [Molecular Function]

Phrase: ")."
Processing 00000000.tx.85: Phosphorylated peptides were identified by selecting for serine/threonine and tyrosine phosphorylation as a variable modification. 

Phrase: "Phosphorylated peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1519061:Phosphorylated Peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "identified by selecting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   756   C1707391:Select [Activity]

Phrase: "for serine/threonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "tyrosine phosphorylation as a variable modification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.86: The exact location of phosphorylation within each peptide was determined by the pattern of fragment ions produced. 

Phrase: "The exact location of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "within each peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "determined by the pattern of fragment ions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   762   C1708097:Fragment Ion [Element, Ion, or Isotope]
   748   C0022023:Ions [Element, Ion, or Isotope]
   748   C0332255:fragment [Functional Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C1708096:Fragment [Qualitative Concept]
   714 E C1700702:ION [Functional Concept]

Phrase: "produced."
Processing 00000000.tx.87: Luciferase AssaysLuciferase assays were performed using a Dual-Glo luciferase assay system according to the manufacturer's instructions (Promega). 

Phrase: "Luciferase AssaysLuciferase assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Dual-Glo luciferase assay system according to the manufacturer's instructions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0449913:System [Functional Concept]
   738   C1553451:System [Manufactured Object]
   738   C1704459:System [Medical Device]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.88: Briefly, cells were harvested into Glo lysis buffer (Promega) 24-h post-transfection and the lysates then transferred to a 96-well luminometer plate (Wallac). 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested into Glo lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
   760   C1536403:lysis [Cell Function]
   726   C1512335:Harvest [Health Care Activity]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "24-h post-transfection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the lysates then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "transferred to a 96-well luminometer plate"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0005971:Plate [Medical Device]
   748   C0205170:Well [Qualitative Concept]
   748   C0348011:transferred [Functional Concept]
   748   C1139930:plate [Medical Device]
   748   C3146287:Well [Manufactured Object]
   748   C3537155:Plate [Manufactured Object]
   714 E C0040671:Transfer [Mental Process]
   714 E C1705822:Transfer [Activity]

Phrase: "(Wallac"

Phrase: ")."
Processing 00000000.tx.89: An equal volume of Dual-Glo luciferase substrate was added and firefly luciferase activities produced by the GAL4UAS-dependent firefly luciferase reporter plasmid pFR-Luc measured using a Wallac Trilux luminometer. 

Phrase: "An equal volume of Dual-Glo luciferase substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0449468:*Volume [Quantitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "firefly luciferase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1324397:firefly luciferase activity [Molecular Function]
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "produced by the GAL4UAS-dependent firefly luciferase reporter plasmid pFR-Luc"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   738   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0162328:Firefly [Eukaryote]
   738   C0335038:Reporter [Professional or Occupational Group]
   738   C0851827:Dependent [Qualitative Concept]
   738   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   738   C1701901:Dependent [Qualitative Concept]
   738   C1705915:Reporter [Conceptual Entity]
   738   C1709908:Reporter [Group]
   738   C3244310:dependent [Functional Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Wallac Trilux luminometer."
Processing 00000000.tx.90: Renilla luciferase activities produced by the phRL-TK transfection efficiency control plasmid were then assayed by adding an equal volume of Dual-Glo Stop&Glo substrate (comprising the stop solution for firefly luciferase and substrate for Renilla luciferase) and remeasuring in the luminometer. 

Phrase: "Renilla luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "produced by the phRL-TK transfection efficiency control plasmid"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0013682:Efficiency [Quantitative Concept]
   742   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   742   C0220928:TK [Geographic Area]
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "assayed by adding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
   756   C1883712:Add [Functional Concept]

Phrase: "an equal volume of Dual-Glo Stop&Glo substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0449468:*Volume [Quantitative Concept]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]

Phrase: "("

Phrase: "comprising"

Phrase: "the stop solution for firefly luciferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "substrate for Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "remeasuring in the luminometer."
Processing 00000000.tx.91: All luciferase transfections received the same number and amount of plasmids, which was achieved by transfection of vector pCIneo-CAT where appropriate; 

Phrase: "All luciferase transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the same number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "amount of plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "achieved by transfection of vector pCIneo-CAT"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0017397:transfection vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0007450:Cat [Mammal]
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0325090:Cat [Mammal]
   748   C0442335:Vector [Spatial Concept]
   748   C0524517:Cat [Mammal]
   748   C1705099:Vector [Idea or Concept]

Phrase: "where appropriate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.92: pCIneo is the vector used for expression of Fe65 in these assays. 

Phrase: "pCIneo"

Phrase: "is"

Phrase: "the vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "used for expression of Fe65"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1273517:used [Finding]
   760   C1412459:FE65 [Gene or Genome]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "in these assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.93: Firefly luciferase activities were standardized to the corresponding Renilla luciferase activities and statistical analyses performed using one-way analysis of variance tests. 

Phrase: "Firefly luciferase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1324397:firefly luciferase activity [Molecular Function]
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "standardized to the corresponding Renilla luciferase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C1151115:luciferase activity [Molecular Function]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0441655:Activities [Activity]
   748   C1093003:Renilla [Eukaryote]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "one-way analysis of variance tests."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   938   C1709320:One-way Analysis of Variance [Quantitative Concept]
   833   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.94: Results shown were obtained using CHO cells, but similar data were obtained using COS-7 cells. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "similar data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "COS-7 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.95: In Vitro Phosphorylation of Fe65 by c-AblXBc-AblXB was isolated from transfected CHO cells by immunoprecipitation using c-Abl antibody 24-11. 

Phrase: "In Vitro Phosphorylation of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "by c-AblXBc-AblXB"

Phrase: "was"

Phrase: "isolated from transfected CHO cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "c-Abl antibody 24-11."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0368815:C ANTIBODY [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1963095:c Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0079050:c abl [Gene or Genome]
   840   C1412097:c-ABL [Gene or Genome]
   840   C1704928:c-Abl [Gene or Genome]
           ABL
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.96: For in vitro phosphorylation of recombinant GST fusion proteins, 1 g of each substrate was incubated with immunoprecipitated kinase (prepared from 200 g of precleared lysate) in 25 mM HEPES pH 7.5 containing 20 mM MgCl2, 20 mM -glycerophosphate, 20 mM p-nitrophenylphosphate, 0.1 mM sodium orthovanadate, 2 mM dithiothreitol, 0.185 MBq [-32P]ATP, and 20 M ATP for 20 min at 30 C in a final volume of 40 l. 

Phrase: "For in vitro phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "of recombinant GST fusion proteins,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   904   C0034857:Recombinant Fusion Proteins [Amino Acid, Peptide, or Protein]
   895   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "1 g of each substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0060916:G-substrate [Amino Acid, Peptide, or Protein]
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   797   C1424668:G-SUBSTRATE [Gene or Genome]
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with immunoprecipitated kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1439852:Incubated [Laboratory Procedure]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "("

Phrase: "prepared from 200 g of precleared lysate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439267:g% [Quantitative Concept]
   748   C1881488:Lysate [Physical Object]
   714   C1521827:Prepare [Functional Concept]

Phrase: ")"

Phrase: "in 25 mM HEPES pH 7.5"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20 mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "20 mM p-nitrophenylphosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0068854:nitrophenylphosphate [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "0.1 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0029366:Orthovanadate [Inorganic Chemical]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "2 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.185 MBq"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0556640:MBq [Quantitative Concept]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP,"

Phrase: "and"

Phrase: "20 M ATP for 20 min"

Phrase: "at 30 C in"

Phrase: "a final volume of 40 l."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.97: Reactions were stopped by addition of SDS sample buffer and heating in a boiling water bath. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by addition of SDS sample buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0370003:Sample [Substance]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   748   C2347026:Sample [Conceptual Entity]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "heating in a boiling water bath."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018851:Heating [Environmental Effect of Humans]
Processing 00000000.tx.98: Samples were separated on 10% (w/v) acrylamide SDS-PAGE gels, and the gels then subjected to autoradiography.  

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated on 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "acrylamide SDS-PAGE gels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "the gels then"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "subjected to autoradiography."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0004400:Autoradiography [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
Processing 00000000.tx.99: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  We initially confirmed that Fe65 interacts with c-Abl and a dominantly active mutant of c-Abl (c-AblXB) using immunoprecipitation and GST pull-down assays. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "interacts with c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704928:ABL [Gene or Genome]

Phrase: "and"

Phrase: "a dominantly active mutant of c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(c-AblXB"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "GST pull-down assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.100: Fe65 from Fe65+c-Abl- or Fe65+c-AblXB-transfected CHO was immunoprecipitated using the Myc tag on Fe65 and bound c-Abl detected on immunoblots. 

Phrase: "Fe65 from Fe65+c-Abl-"

Phrase: "or"

Phrase: "Fe65+c-AblXB-transfected CHO"

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Myc tag on Fe65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
   760   C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "bound c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "detected on immunoblots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.101: Fe65 interacted with both c-Abl and c-AblXB but the binding to c-AblXB was stronger (Fig. 1A). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "interacted with both c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704928:ABL [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "but"

Phrase: "the binding to c-AblXB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "stronger"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.102: In complementary experiments, GST or GST-Fe65WW domain baits were used in pull-down assays from c-Abl- or c-AblXB-transfected CHO cells. 

Phrase: "In complementary experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "GST-Fe65WW domain baits"

Phrase: "were"

Phrase: "used in pull-down assays"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0580846:pull [Finding]
   760   C1273517:used [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "from c-Abl-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "c-AblXB-transfected CHO cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   881   C0229579:C-Cell [Cell]
   840   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.103: Again, both c-Abl and c-AblXB bound Fe65 with the c-AblXB interaction stronger (Fig. 1B). 

Phrase: "Again,"

Phrase: "both c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "Fe65 with the c-AblXB interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1412459:FE65 [Gene or Genome]

Phrase: "stronger"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: Mutation of the conserved aromatic residues Tyr-Tyr-Trp within the Fe65WW domain to Ala-Ala-Ala inhibited binding of c-AblXB (Fig. 1C). 

Phrase: "Mutation of the conserved aromatic residues Tyr-Tyr-Trp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within the Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "to Ala-Ala-Ala"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051069:Ala-Ala-Ala [Amino Acid, Peptide, or Protein]
   734   C0051078:Ala-Ala [Amino Acid, Peptide, or Protein]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "binding of c-AblXB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.105: We also monitored c-Abl expression by immunostaining of Fe65+c-Abl- and Fe65+c-AblXB-co-transfected CHO and COS-7 cells. 

Phrase: "We also monitored c-Abl expression by immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Fe65+c-Abl-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "and"

Phrase: "Fe65+c-AblXB-"

Phrase: "co-transfected"

Phrase: "CHO"

Phrase: "and"

Phrase: "COS-7 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.106: Fe65, c-Abl, and c-AblXB were all present in both the cytoplasm and nuclei of these cells, and Fe65 and c-Abl/c-AblXB showed a marked overlap in their distributions (Fig. 1D). 

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "c-Abl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "were"

Phrase: "all"

Phrase: "present in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nuclei of these cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   859   C0007610:Nucleus of cell [Cell Component]
           Cell Nuclei
           Nucleus

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-Abl/c-AblXB"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a marked overlap in their distributions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185027:overlap [Therapeutic or Preventive Procedure]
   753   C1948020:Overlap [Conceptual Entity]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.107: These results are in agreement with previous observations, which demonstrate that Fe65 binds to c-Abl through its WW domain, that this interaction is stronger with active isoforms of c-Abl, and that a proportion of both Fe65 and c-Abl are present within the nucleus (27, 30). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with previous observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "which"

Phrase: "demonstrate"

Phrase: "that Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "binds to c-Abl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1704928:ABL [Gene or Genome]

Phrase: "through its WW domain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1861696:WW [Disease or Syndrome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "stronger with active isoforms of c-Abl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0442821:Strong [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "a proportion of both Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "are"

Phrase: "present within the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(27,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.108: View larger version (59K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.110: Fe65 binds to c-Abl and c-AblXB through its WW domain, and Fe65 and c-Abl are both present in the nucleus. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "binds to c-Abl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1704928:ABL [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB through its WW domain,"

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "are"

Phrase: "both present in the nucleus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.111: A, the presence of c-Abl and c-AblXB in Fe65 immunoprecipitates from Fe65+c-Abl- and Fe65+c-AblXB-co-transfected cells. 

Phrase: "A,"

Phrase: "the presence of c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "c-AblXB in Fe65"

Phrase: "immunoprecipitates from Fe65+c-Abl-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301871:Immunoprecipitate [Immunologic Factor]
   760   C1412459:FE65 [Gene or Genome]
   760   C1704928:ABL [Gene or Genome]

Phrase: "and"

Phrase: "Fe65+c-AblXB-"

Phrase: "co-transfected"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: Fe65 was immunoprecipitated using antibody 9B11 to the Myc tag, and the immunoprecipitates were then probed on immunoblots for Fe65 (using a polyclonal Fe65 antibody), c-Abl, or c-AblXB as indicated. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 9B11 to the Myc tag,"

Phrase: "and"

Phrase: "the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed on immunoblots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0020985:Immunoblot [Laboratory Procedure]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "for Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a polyclonal Fe65 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "c-Abl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "c-AblXB"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.113: Samples of the lysates are also shown. 

Phrase: "Samples of the lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.114: (+) and (-) refer to the presence or absence of antibody 9B11 to the Fe65 Myc tag in the immunoprecipitations. 

Phrase: "(+"

Phrase: ")"

Phrase: "and (-)"

Phrase: "refer to the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205543:refer [Functional Concept]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of antibody 9B11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "to the Fe65 Myc tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "in the immunoprecipitations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.115: B, GST pull-downs from c-Abl- or c-AblXB-transfected cells using equimolar amounts of GST or GST-Fe65WW domain baits as indicated. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "GST pull-downs from c-Abl-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0580846:pull [Finding]

Phrase: "or"

Phrase: "c-AblXB-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0229579:C-Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "equimolar amounts of GST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "or"

Phrase: "GST-Fe65WW domain baits"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.116: Captured proteins were probed for c-Abl on immunoblots. 

Phrase: "Captured proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "probed for c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1704928:ABL [Gene or Genome]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "on immunoblots."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.117: Samples of the lysates are also shown. 

Phrase: "Samples of the lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.118: Note that Fe65 binds a greater proportion of c-AblXB than c-Abl in both assays. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "a greater proportion of c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "than c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "in both assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.119: C, GST pull-downs from c-AblXB-transfected cells using as baits equimolar amounts of GST, GST-Fe65WW domain, or a GST-Fe65WW mutant involving altering the Tyr-Tyr-Trp motif to Ala-Ala-Ala (GST-Fe65mWW). 

Phrase: "C,"

Phrase: "GST pull-downs from c-AblXB-transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0580846:pull [Finding]

Phrase: "using as baits equimolar amounts of GST,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   745   C1524063:Use of [Functional Concept]
           Using
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1265611:amounts [Quantitative Concept]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "GST-Fe65WW domain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "a GST-Fe65WW mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the Tyr-Tyr-Trp motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "to Ala-Ala-Ala (GST-Fe65mWW"

Phrase: ")."
Processing 00000000.tx.120: Captured proteins were probed for c-Abl on immunoblots. 

Phrase: "Captured proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "probed for c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1704928:ABL [Gene or Genome]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "on immunoblots."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.121: A sample of the lysate is also shown. 

Phrase: "A sample of the lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "is"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.122: GST-Fe65mWW binds less c-AblXB than GST-Fe65WW. 

Phrase: "GST-Fe65mWW"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "less c-AblXB than GST-Fe65WW."
Processing 00000000.tx.123: D, immunofluorescent staining of Fe65 and c-Abl in Fe65+c-Abl- and Fe65+c-AblXB-co-transfected cells. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "immunofluorescent staining of Fe65"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "c-Abl in Fe65+c-Abl-"

Phrase: "and"

Phrase: "Fe65+c-AblXB-"

Phrase: "co-transfected"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.124: Scale bar in C is 10 m.  

Phrase: "Scale bar in C"

Phrase: "is"

Phrase: "10 m."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.125: We next examined the effect of c-AblXB on APP/Fe65-mediated transcription. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65-mediated transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.126: To do so, we utilized a previously described GAL4-dependent reporter system that involves monitoring the transcriptional activity of APP-GAL4 DNA binding domain fusion genes using a GAL4UAS-luciferease reporter (19). 

Phrase: "To do so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883351:To [Qualitative Concept]

Phrase: "we"

Phrase: "utilized"

Phrase: "a previously described GAL4-dependent reporter system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "that"

Phrase: "involves"

Phrase: "monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]

Phrase: "the transcriptional activity of APP-GAL4 DNA binding domain fusion genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C1325278:amyloid protein activity [Molecular Function]
   749   C1537044:protein activity [Molecular Function]
   749   C2266866:Binding Activity [Molecular Function]
   735   C0205177:Activity [Functional Concept]
   735   C0439167:% activity [Quantitative Concept]
   735   C0441655:Activity [Activity]
   735   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a GAL4UAS-luciferease reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0335038:Reporter [Professional or Occupational Group]
   827   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   827   C1705915:Reporter [Conceptual Entity]
   827   C1709908:Reporter [Group]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.127: GAL4-APP fusions involved either the GAL4 DNA binding domain fused to the C-terminal domain of APP (GAL4-APPc) or full-length APP into which the GAL4 DNA binding domain had been engineered (GAL4-APP) (19). 

Phrase: "GAL4-APP fusions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332466:fusions [Functional Concept]
   804   C1293131:fusions [Therapeutic or Preventive Procedure]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "either"

Phrase: "the GAL4 DNA binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "fused to the C-terminal domain of APP"
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1707271:C-Terminal [Amino Acid Sequence]
   757   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1168438:Protein C [Laboratory Procedure]
   757   C1418943:PROTEIN C [Gene or Genome]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   757   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205088:Terminal [Temporal Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0699952:Fused [Functional Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
   706 E C1414861:FUSE [Gene or Genome]
   706 E C1708111:Fuse [Manufactured Object]

Phrase: "(GAL4-APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "or"

Phrase: "full-length APP into which"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "the GAL4 DNA binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "had"

Phrase: "been"

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "(GAL4-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.128: Both GAL4-APPc and GAL4-APP transcription was stimulated by transfection of Fe65, and this stimulation was enhanced further by co-transfection with c-AblXB (Fig. 2). 

Phrase: "Both GAL4-APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "GAL4-APP transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "was"

Phrase: "stimulated by transfection of Fe65,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C1412459:FE65 [Gene or Genome]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "this stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "further by co-transfection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]

Phrase: "with c-AblXB"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.129: c-AblXB also stimulated transcription of the reporter in the absence of co-transfected Fe65, although to a lesser extent (Fig. 2). 

Phrase: "c-AblXB also stimulated transcription of the reporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040649:Transcription [Genetic Function]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of"

Phrase: "co-transfected"

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "although to a lesser extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.130: This effect of c-AblXB in the absence of co-transfected Fe65 may well involve endogenous Fe65, because Fe65 is expressed in CHO and COS-7 cells (42). 

Phrase: "This effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of"

Phrase: "co-transfected"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "involve"

Phrase: "endogenous Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "because"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "expressed in CHO"

Phrase: "and"

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.131: Mutation of the conserved aromatic residues Tyr-Tyr-Trp within the Fe65WW domain to Ala-Ala-Ala markedly inhibited its stimulatory effect (Fig. 2). 

Phrase: "Mutation of the conserved aromatic residues Tyr-Tyr-Trp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within the Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "to Ala-Ala-Ala markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   923   C0051069:Ala-Ala-Ala [Amino Acid, Peptide, or Protein]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "its stimulatory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.132: This finding is consistent with the GST pull-down assays, which showed that this mutation inhibited binding of the WW domain to c-AblXB (Fig. 1C). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with the GST pull-down assays,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "binding of the WW domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   844   C1323337:WW domain binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1861696:WW [Disease or Syndrome]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "to c-AblXB"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.133: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.134: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.135: Fe65 and c-AblXB stimulate transcription of APP proteins fused to the GAL4 DNA binding domain. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "stimulate"

Phrase: "transcription of APP proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040649:Transcription [Genetic Function]

Phrase: "fused to the GAL4 DNA binding domain."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   814   C1511662:DNA Binding Domain [Amino Acid Sequence]
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0699952:Fused [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.136: A, transcription induced by a fusion gene comprising the GAL4 DNA binding domain fused to the C-terminal domain of APP (GAL4-APPc) is stimulated by Fe65, c-AblXB, and Fe65+c-AblXB. 

Phrase: "A,"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "induced by a fusion gene"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1533585:Fusion Gene [Gene or Genome]
   797 E C0178648:Gene Fusion [Molecular Biology Research Technique]
   797 E C1705736:Gene Fusion [Cell or Molecular Dysfunction]
   760   C0017337:Gene [Gene or Genome]
   760   C0205263:Induced [Functional Concept]
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "comprising"

Phrase: "the GAL4 DNA binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "fused to the C-terminal domain of APP"
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1707271:C-Terminal [Amino Acid Sequence]
   757   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1168438:Protein C [Laboratory Procedure]
   757   C1418943:PROTEIN C [Gene or Genome]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   757   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205088:Terminal [Temporal Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0699952:Fused [Functional Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
   706 E C1414861:FUSE [Gene or Genome]
   706 E C1708111:Fuse [Manufactured Object]

Phrase: "(GAL4-APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "is"

Phrase: "stimulated by Fe65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1412459:FE65 [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "c-AblXB,"

Phrase: "and"

Phrase: "Fe65+c-AblXB."
Processing 00000000.tx.137: Fe65 stimulates transcription (p < 0.001), although this is significantly inhibited by mutation of the Fe65WW domain (Fe65mWW) (Fe65 versus Fe65mWW, p < 0.001). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "stimulates"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "this"

Phrase: "is"

Phrase: "significantly"

Phrase: "inhibited by mutation of the Fe65WW domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0026882:Mutation [Genetic Function]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "(Fe65mWW"

Phrase: ")"

Phrase: "(Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "versus"

Phrase: "Fe65mWW,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.138: Transcription is mildly stimulated by c-AblXB alone (p < 0.001) and potently stimulated by Fe65+c-AblXB (p < 0.001). 

Phrase: "Transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "mildly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750532:MILDLY [Idea or Concept]
  1000   C2945599:Mildly [Qualitative Concept]

Phrase: "stimulated by c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "potently"

Phrase: "stimulated by Fe65+c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1412459:FE65 [Gene or Genome]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.139: Mutation of the Fe65WW domain again markedly inhibits this effect (Fe65+c-AblXB versus Fe65mWW+c-AblXB, p < 0.001). 

Phrase: "Mutation of the Fe65WW domain again markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(Fe65+c-AblXB"

Phrase: "versus"

Phrase: "Fe65mWW+c-AblXB,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.140: B, a similar experiment using a full-length APP-GAL4 DNA binding domain fusion gene to drive reporter gene expression (GAL4-APP). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a similar experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a full-length APP-GAL4 DNA binding domain fusion gene to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1533585:Fusion Gene [Gene or Genome]
   787   C0017337:Gene [Gene or Genome]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "reporter gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(GAL4-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.141: Again, Fe65 stimulates transcription (p < 0.001), but this is significantly inhibited by mutation of the Fe656WW domain (Fe65 versus Fe65mWW, p < 0.001). 

Phrase: "Again,"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "stimulates"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "this"

Phrase: "is"

Phrase: "significantly"

Phrase: "inhibited by mutation of the Fe656WW domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0026882:Mutation [Genetic Function]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "(Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "versus"

Phrase: "Fe65mWW,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.142: Transcription is mildly stimulated by c-AblXB alone (p < 0.001) and potently stimulated by Fe65+c-AblXB (p < 0.001). 

Phrase: "Transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "mildly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750532:MILDLY [Idea or Concept]
  1000   C2945599:Mildly [Qualitative Concept]

Phrase: "stimulated by c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "potently"

Phrase: "stimulated by Fe65+c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1412459:FE65 [Gene or Genome]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.143: Mutation of the Fe65WW domain markedly inhibits this effect (Fe65+c-AblXB versus Fe65mWW+c-AblXB, p < 0.001). 

Phrase: "Mutation of the Fe65WW domain markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(Fe65+c-AblXB"

Phrase: "versus"

Phrase: "Fe65mWW+c-AblXB,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.144: Results shown are from 12 (A) and 16 (B) transfections; 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are from 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "16"

Phrase: "(B) transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: ";"
Processing 00000000.tx.145: error bars are S.E. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "are S.E."
Processing 00000000.tx.146: C, schematic of GAL4-APP fusion proteins used in this study with APP ectoplasmic and cytoplasmic domains (APPe, APPc), GAL4 DNA binding domain (GAL4DNAbd) and membrane (m) are highlighted.  

Phrase: "C,"

Phrase: "schematic of GAL4-APP fusion proteins"

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "ectoplasmic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0598267:Ectoplasm [Cell Component]

Phrase: "and"

Phrase: "cytoplasmic domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1511625:Cytoplasmic Domain [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(APPe,"

Phrase: "APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "GAL4 DNA binding domain (GAL4DNAbd)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "membrane (m)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "are"

Phrase: "highlighted."
Processing 00000000.tx.147: Tyrosine 682 within the intracellular C-terminal domain of APP has been shown to be phosphorylated by active c-Abl (27), and so one possibility is that the effect of c-AblXB on APP/Fe65-mediated transcription is due to phosphorylation of this residue. 

Phrase: "Tyrosine 682 within the intracellular C-terminal domain of APP"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1707271:C-Terminal [Amino Acid Sequence]
   751   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C0162808:Protein Domain [Spatial Concept]
   751   C1168438:Protein C [Laboratory Procedure]
   751   C1418943:PROTEIN C [Gene or Genome]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C1514562:Protein Domain [Amino Acid Sequence]
   751   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0175996:intracellular [Cell Component]
   736   C0178719:Intracellular [Spatial Concept]
   736   C0205088:Terminal [Temporal Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1709634:Precursor [Idea or Concept]
   736   C1880389:Domain [Functional Concept]
   736   C1883221:Domain [Conceptual Entity]
   736   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated by active c-Abl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205177:Active [Functional Concept]
   760   C1704928:ABL [Gene or Genome]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "so one possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C0332149:Possible [Qualitative Concept]
   755   C1705910:Possible [Qualitative Concept]
   755   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040649:Transcription [Genetic Function]

Phrase: "is due to phosphorylation of this residue."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]
   748   C3146286:Due [Idea or Concept]
Processing 00000000.tx.148: We therefore confirmed that c-AblXB phosphorylated APPTyr-682 by monitoring the reactivity of APP and a mutant of APP in which tyrosine 682 was altered to phenylalanine with antibody 4G10 that detects phosphotyrosines. 

Phrase: "We therefore"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that c-AblXB"

Phrase: "phosphorylated"

Phrase: "APPTyr-682 by monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150369:Monitoring [Health Care Activity]
   770   C1516647:monitoring [Research Activity]

Phrase: "the reactivity of APP"

Phrase: "and"

Phrase: "a mutant of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "in which tyrosine 682"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "altered to phenylalanine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0392747:Altered [Functional Concept]

Phrase: "with antibody 4G10"

Phrase: "that"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "phosphotyrosines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.149: APP immunoprecipitated from APP+c-AblXB- but not APP-transfected cells was reactive with antibody 4G10, and this reactivity was abolished by mutation of APPTyr-682 (Fig. 3A). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "immunoprecipitated from APP+c-AblXB-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1168438:Protein C [Laboratory Procedure]
   778   C1418943:PROTEIN C [Gene or Genome]
   778   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "but"

Phrase: "not APP-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   841   C0018956:precursor cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "reactive with antibody 4G10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "this reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205332:Reactive [Qualitative Concept]

Phrase: "was"

Phrase: "abolished by mutation of APPTyr-682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.150: Thus, we confirmed that APPTyr-682 is phosphorylated in APP+c-AblXB-transfected cells as previously described (27). 

Phrase: "Thus,"

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that APPTyr-682"

Phrase: "is"

Phrase: "phosphorylated in APP+c-AblXB-transfected cells"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1168438:Protein C [Laboratory Procedure]
   764   C1418943:PROTEIN C [Gene or Genome]
   764   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.151: View larger version (43K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.152: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.153: c-AblXB phosphorylates APP and Fe65. 

Phrase: "c-AblXB"

Phrase: "phosphorylates"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.154: A, phosphorylation of APPTyr-682 in cells transfected with APP and c-AblXB. 

Phrase: "A,"

Phrase: "phosphorylation of APPTyr-682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "c-AblXB."
Processing 00000000.tx.155: APP or mutant APPY682F was immunoprecipitated from either APP-only- or APP+c-AblXB-transfected cells. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "mutant APPY682F"

Phrase: "was"

Phrase: "immunoprecipitated from either APP-only-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205171:Only [Quantitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   748   C1720467:Only [Intellectual Product]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "APP+c-AblXB-transfected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   860   C0018956:precursor cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: The samples were then probed on immunoblots with antibody 4G10 (pTyr) that detects phosphotyrosines, antibody 22C11 to APP (APP), and antibody 24-11 to c-Abl. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed on immunoblots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0020985:Immunoblot [Laboratory Procedure]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "with antibody 4G10"

Phrase: "(pTyr"

Phrase: ")"

Phrase: "that"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "phosphotyrosines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "antibody 22C11 to APP"

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "antibody 24-11 to c-Abl."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1704928:ABL [Gene or Genome]
Processing 00000000.tx.157: Wild-type but not APPY682F reacts with 4G10. 

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "not APPY682F"

Phrase: "reacts with 4G10."
Processing 00000000.tx.158: (+) and (-) refer to the presence or absence of antibody APPab in the immunoprecipitations. 

Phrase: "(+"

Phrase: ")"

Phrase: "and (-)"

Phrase: "refer to the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205543:refer [Functional Concept]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of antibody APPab"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the immunoprecipitations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.159: B, tandem MS/MS spectra for Fe65 phosphopeptide FQVYYLGNVPVAKPVGVDVINGALESVLSSSSR (Mr 3544.35) (residues 543575). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "tandem MS/MS spectra for Fe65 phosphopeptide FQVYYLGNVPVAKPVGVDVINGALESVLSSSSR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Mr 3544.35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347167:Mr. [Conceptual Entity]

Phrase: ")"

Phrase: "(residues 543575"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.160: The triply charged precursor ion of the phosphorylated peptide, with an m/z of 1182.463+, was sequenced by collision-induced fragmentation. 

Phrase: "The triply charged precursor ion of the phosphorylated peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0022023:Ion [Element, Ion, or Isotope]
   742   C1700702:ION [Functional Concept]

Phrase: "with an m/z"

Phrase: "of 1182.463+,"

Phrase: "was"

Phrase: "sequenced by collision-induced fragmentation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205263:Induced [Functional Concept]
   760   C0332472:Fragmentation [Anatomical Abnormality]
   760   C0337196:Collision [Injury or Poisoning]
   760   C1881708:FRAGMENTATION [Phenomenon or Process]
   726   C0004793:Sequence [Nucleotide Sequence]
   726   C0162326:Sequence [Nucleotide Sequence]
   726   C0162327:Sequence [Nucleotide Sequence]
   726   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.161: The m/z of the fragment ions is plotted against intensity. 

Phrase: "The m/z of the fragment ions"

Phrase: "is"

Phrase: "plotted against intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.162: The peptide mass and the m/z of the fragment ions in the b ion series (nomenclature as described by Ref. 50) show a tyrosine-phosphorylated peptide with the phosphate located on either Tyr-546 or Tyr-547. 

Phrase: "The peptide mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "the m/z of the fragment ions"

Phrase: "in the b ion series"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]
   734   C2346898:B-ion [Element, Ion, or Isotope]

Phrase: "(nomenclature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600281:Nomenclature [Intellectual Product]
  1000   C1524067:Nomenclature [Intellectual Product]

Phrase: "as"

Phrase: "described by Ref. 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1425988:REF [Gene or Genome]
   770   C1552738:described [Idea or Concept]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a tyrosine-phosphorylated peptide with the phosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1519061:Phosphorylated Peptide [Amino Acid, Peptide, or Protein]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "located on either Tyr-546"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1421250:TYR [Gene or Genome]

Phrase: "or"

Phrase: "Tyr-547."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]
Processing 00000000.tx.163: The absence of the b4 ion within the MS/MS fragmentation spectrum prevents the assignment of the phosphorylation to a specific tyrosine residue. 

Phrase: "The absence of the b4 ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "within the MS/MS fragmentation spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1883073:Spectrum [Quantitative Concept]
   812   C2827424:Spectrum [Conceptual Entity]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the assignment of the phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516050:Assignment [Functional Concept]

Phrase: "to a specific tyrosine residue."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.164: C, tyrosine phosphorylation of Fe65 in cells transfected with Fe65 and c-AblXB. 

Phrase: "C,"

Phrase: "tyrosine phosphorylation of Fe65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1519726:Tyrosine Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB."
Processing 00000000.tx.165: Fe65 was immunoprecipitated from cells transfected with wild-type Fe65 (Fe65) or mutants of Fe65 in which each tyrosine was mutated to phenylalanine (Y117F, Y234F, Y269F, Y270F, Y403F, Y467F, Y546F, Y547F, Y658F) either alone or with c-AblXB as indicated. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756   C0301871:Immunoprecipitate [Immunologic Factor]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild-type Fe65"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1412459:FE65 [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "mutants of Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in which"

Phrase: "each tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "mutated to phenylalanine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "(Y117F,"

Phrase: "Y234F,"

Phrase: "Y269F,"

Phrase: "Y270F,"

Phrase: "Y403F,"

Phrase: "Y467F,"

Phrase: "Y546F,"

Phrase: "Y547F,"

Phrase: "Y658F"

Phrase: ")"

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or with c-AblXB"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.166: The samples were then probed on immunoblots for both Fe65 and co-immunoprecipitating c-AblXB and for tyrosine phosphorylation of these using antibody 4G10 (pTyr). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed on immunoblots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0020985:Immunoblot [Laboratory Procedure]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "for both Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "co-immunoprecipitating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "c-AblXB"

Phrase: "and for tyrosine phosphorylation of these"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1515981:And [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 4G10"

Phrase: "(pTyr"

Phrase: ")."
Processing 00000000.tx.167: Fe65 tyrosine phosphorylation is detected only in the presence of c-AblXB and only mutation of Fe65Tyr-547 (Y547F) abrogates this phosphorylation. 

Phrase: "Fe65 tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1519726:Tyrosine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only in the presence of c-AblXB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205171:Only [Quantitative Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "only mutation of Fe65Tyr-547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Y547F"

Phrase: ")"

Phrase: "abrogates"

Phrase: "this phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.168: Tyrosine autophosphorylation of c-AblXB (which has previously been described (30) is seen in all samples. 

Phrase: "Tyrosine autophosphorylation of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C3271785:tyrosine autophosphorylation [Molecular Function]
   760   C0813988:autophosphorylation [Molecular Function]

Phrase: "("

Phrase: "which"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(30"

Phrase: ")"

Phrase: "is"

Phrase: "seen in all samples."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737   C0370003:Sample [Substance]
   737 E C1947903:See [Activity]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.169: D, in vitro phosphorylation of GST-Fe65PTB2 domain (that harbors tyrosine 547) by c-AblXB. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in vitro phosphorylation of GST-Fe65PTB2 domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "("

Phrase: "that harbors tyrosine 547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C0475311:Harbor [Manufactured Object]

Phrase: ")"

Phrase: "by c-AblXB."
Processing 00000000.tx.170: GST or GST-Fe65PTB2 domain were phosphorylated with [-32P]ATP and c-AblXB. 

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "GST-Fe65PTB2 domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "phosphorylated with"

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "c-AblXB."
Processing 00000000.tx.171: RM is reaction mix only with no substrate; 

Phrase: "RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2951520:RM [Body Location or Region]

Phrase: "is"

Phrase: "reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205430:Mix [Functional Concept]
  1000   C1421951:MIX [Gene or Genome]
  1000   C1720722:Mix [Qualitative Concept]

Phrase: "only with no substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C1710236:Substrate [Manufactured Object]
   770   C1720467:Only [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.172: GST-Fe65PTB2 and GST substrates are as indicated. 

Phrase: "GST-Fe65PTB2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase

Phrase: "and"

Phrase: "GST substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1710236:Substrate [Manufactured Object]
   756   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase

Phrase: "are"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.173: (+) and (-) refer to the presence or absence of c-Abl antibody in the kinase immunoprecipitations. 

Phrase: "(+"

Phrase: ")"

Phrase: "and (-)"

Phrase: "refer to the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205543:refer [Functional Concept]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of c-Abl antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the kinase immunoprecipitations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.174: The upper panels show the autoradiographs, the lower panels are the corresponding Coomassie-stained gels.  

Phrase: "The upper panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the autoradiographs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C2986957:Autoradiograph [Manufactured Object]
   893 E C0004400:Autoradiography [Laboratory Procedure]

Phrase: "the lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "are"

Phrase: "the corresponding Coomassie-stained gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]
Processing 00000000.tx.175: An alternative possibility is that c-Abl also phosphorylates Fe65, and the stimulatory effect of c-AblXB on transcription is caused by Fe65 phosphorylation. 

Phrase: "An alternative possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that c-Abl also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0079050:c abl [Gene or Genome]
   901   C1412097:c-ABL [Gene or Genome]
   901   C1704928:c-Abl [Gene or Genome]
           ABL
   827   C1553033:[c] [Quantitative Concept]

Phrase: "phosphorylates"

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "caused by Fe65 phosphorylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1412459:FE65 [Gene or Genome]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.176: We therefore isolated Fe65 by immunoprecipitation from Fe65- or Fe65+c-AblXB-co-transfected cells, and it was sequenced by mass spectrometry. 

Phrase: "We therefore isolated Fe65 by immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1412459:FE65 [Gene or Genome]

Phrase: "from Fe65-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "or"

Phrase: "Fe65+c-AblXB-"

Phrase: "co-transfected"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "sequenced by mass spectrometry."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.177: We obtained over 80% sequence coverage and detected one peptide with a phosphorylated tyrosine residue (Fig. 3B). 

Phrase: "We"

Phrase: "obtained over 80% sequence coverage"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1301820:Obtained [Functional Concept]
   760   C1519249:Sequence [Functional Concept]
   760   C1551362:coverage [Idea or Concept]
   760   C1999244:Coverage [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "detected one peptide with a phosphorylated tyrosine residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1519061:Phosphorylated Peptide [Amino Acid, Peptide, or Protein]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.178: This peptide contains two adjacent tyrosines (tyrosines 546/547), although despite repeated sequence runs, we were unable to unambiguously distinguish which tyrosine was phosphorylated. 

Phrase: "This peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two adjacent tyrosines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(tyrosines 546/547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "although despite repeated sequence runs,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205341:Repeated [Functional Concept]
   760   C0600140:Runs [Finding]
   760   C1519249:Sequence [Functional Concept]
   726 E C0035953:run [Daily or Recreational Activity]
   726 E C1704688:Run [Functional Concept]
   726 E C2346414:Run [Finding]

Phrase: "we"

Phrase: "were"

Phrase: "unable to unambiguously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1299582:Unable [Finding]

Phrase: "distinguish"

Phrase: "which tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "phosphorylated."
Processing 00000000.tx.179: We therefore prepared mutants of Fe65 in which either of these tyrosines were mutated to phenylalanine to preclude phosphorylation and examined their reactivities with antibody 4G10 in Fe65+c-AblXB-co-transfected cells. 

Phrase: "We therefore prepared mutants of Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in which either"

Phrase: "of these tyrosines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "mutated to phenylalanine to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1705285:Mutated [Cell or Molecular Dysfunction]
   737 E C1513776:Mutate [Genetic Function]

Phrase: "preclude"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "their reactivities with antibody 4G10"

Phrase: "in Fe65+c-AblXB-"

Phrase: "co-transfected"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.180: Immunoprecipitated Fe65Y546F but not Fe65Y547F was reactive with 4G10 in these assays (Fig. 3C). 

Phrase: "Immunoprecipitated Fe65Y546F"

Phrase: "but"

Phrase: "not Fe65Y547F"

Phrase: "was"

Phrase: "reactive with 4G10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205332:Reactive [Qualitative Concept]

Phrase: "in these assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: To confirm that no other tyrosines in Fe65 were phosphorylated in the Fe65+c-AblXB-co-transfected cells, we mutated individually, the remaining seven tyrosines to phenylalanine, and in a similar fashion, monitored the reactivities of these mutants with antibody 4G10. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "no other tyrosines in Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "phosphorylated in the Fe65+c-AblXB-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1412459:FE65 [Gene or Genome]

Phrase: "co-transfected"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "individually,"

Phrase: "the remaining seven tyrosines to phenylalanine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0369827:Phenylalanine+Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C3536767:Phenylalanine/Tyrosine [Quantitative Concept]
   719   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and in a similar fashion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515981:And [Idea or Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "the reactivities of these mutants"

Phrase: "with antibody 4G10."
Processing 00000000.tx.182: Mutation of these other tyrosines had no effect on 4G10 labeling (Fig. 3C). 

Phrase: "Mutation of these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "other tyrosines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect on 4G10 labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.183: Thus, Fe65 is phosphorylated on a single residue, tyrosine 547, in c-AblXB-transfected cells. 

Phrase: "Thus,"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated on a single residue,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "tyrosine 547,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in c-AblXB-transfected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0229579:C-Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.184: The above studies are consistent with a direct phosphorylation of Fe65 by c-AblXB but do not eliminate the possibility that c-AblXB activates some other tyrosine kinase that then phosphorylates Fe65. 

Phrase: "The above studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "consistent with a direct phosphorylation of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by c-AblXB"

Phrase: "but"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "eliminate"

Phrase: "the possibility"

Phrase: "that c-AblXB"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "some other tyrosine kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "that then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "phosphorylates"

Phrase: "Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.185: To determine whether c-AblXB can directly phosphorylate Fe65, we therefore performed in vitro phosphorylation assays using the second Fe65-PTB domain (which contains tyrosine 547) prepared as a GST fusion protein substrate. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "c-AblXB"

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "we therefore"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in vitro phosphorylation assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C1515653:In Vitro Assay [Research Activity]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the second Fe65-PTB domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "("

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "prepared as a GST fusion protein substrate."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   764   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1418948:PROTEIN S [Gene or Genome]
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   742   C1710236:Substrate [Manufactured Object]
   708   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.186: These assays revealed that c-AblXB could directly phosphorylate Fe65 (Fig. 3D). 

Phrase: "These assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that c-AblXB"

Phrase: "could"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.187: Thus c-Abl can directly phosphorylate both APP (on tyrosine 682) and Fe65 (on tyrosine 547). 

Phrase: "Thus c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "on tyrosine 682"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "("

Phrase: "on tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.188: To examine whether the stimulatory effect of c-AblXB on APP/Fe65-mediated transcription involves phosphorylation of either APPTyr-682 or Fe65Tyr-547, we performed further GAL4-APPc-dependent transcription assays using mutants in which these residues were altered to phenylalanine to preclude phosphorylation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040649:Transcription [Genetic Function]

Phrase: "involves"

Phrase: "phosphorylation of either APPTyr-682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "Fe65Tyr-547,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "further GAL4-APPc-dependent transcription assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0040649:Transcription [Genetic Function]
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mutants in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "altered to phenylalanine to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0392747:Altered [Functional Concept]

Phrase: "preclude"

Phrase: "phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.189: Fe65 and c-AblXB both stimulated transcription of mutant GAL4-APPcY682F, and this stimulation was greater than that of wild-type GAL4-APPc (Fig. 4A). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "both stimulated transcription of mutant GAL4-APPcY682F,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "this stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "greater than that of wild-type GAL4-APPc"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439093:Greater Than [Quantitative Concept]
   744   C0443228:greater [Quantitative Concept]
   744   C1704243:Greater [Quantitative Concept]
   711 E C0549177:Great [Quantitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.190: Others have also shown that mutation of APP682 to phenylalanine enhances transcriptional activity of GAL4-APP fusions (43). 

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that mutation of APP682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "transcriptional activity of GAL4-APP fusions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C1325278:amyloid protein activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.191: The mechanisms that underlie this effect are not known but mutation of APP682 to phenylalanine does not influence either APP/Fe65 or APP/JIP-1 interactions (Ref. 43 and see below). 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underlie"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "but"

Phrase: "mutation of APP682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "either APP/Fe65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412459:FE65 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "or"

Phrase: "APP/JIP-1 interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0872079:protein interaction [Molecular Function]
   766   C1704675:Interaction [Functional Concept]

Phrase: "(Ref. 43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.192: Thus, the stimulatory effect of c-AblXB on APP/Fe65 transcription cannot be through phosphorylation of APP682. 

Phrase: "Thus,"

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65 transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "cannot"

Phrase: "be through phosphorylation of APP682."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.193: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.194: 4. 

Phrase: "4."
Processing 00000000.tx.195: Phosphorylation of Fe65Tyr-547 but not APPTyr-682 by c-AblXB stimulates APP/Fe65 transcription. 

Phrase: "Phosphorylation of Fe65Tyr-547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "but"

Phrase: "not APPTyr-682 by c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1518422:Not [Functional Concept]

Phrase: "stimulates"

Phrase: "APP/Fe65 transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.196: A, transcription induced by GAL4-APPc/Fe65 is stimulated by c-AblXB, but mutation of Fe65Tyr-547 but not APPTyr-682 (both of which are phosphorylated by c-AblXB) to preclude phosphorylation blocks the effect of c-AblXB. 

Phrase: "A,"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "induced by GAL4-APPc/Fe65"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0052145:APPC [Antibiotic,Organic Chemical]
   760   C0205263:Induced [Functional Concept]
   760   C1412459:FE65 [Gene or Genome]
   760   C1416832:GAL4 [Gene or Genome]

Phrase: "is"

Phrase: "stimulated by c-AblXB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "mutation of Fe65Tyr-547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "not APPTyr-682"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "("

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "are"

Phrase: "phosphorylated by c-AblXB"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "preclude"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the effect of c-AblXB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.197: Mutants Fe65Y546F and Fe65Y547F do not significantly alter Fe65 stimulation. 

Phrase: "Mutants Fe65Y546F"

Phrase: "and"

Phrase: "Fe65Y547F"

Phrase: "do"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "Fe65 stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.198: Mutant Fe65Y547F but not Fe65Y546F blocks the stimulatory effect of c-AblXB (GAL4-APPc+Fe65+c-AblXB versus GAL4-APPc+Fe65Y546F+c-AblXB, no significant difference; GAL4-APPc+Fe65+c-AblXB versus GAL4-APPc+Fe65Y547F+c-AblXB, p < 0.001). 

Phrase: "Mutant Fe65Y547F"

Phrase: "but"

Phrase: "not Fe65Y546F"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(GAL4-APPc+Fe65+c-AblXB"

Phrase: "versus"

Phrase: "GAL4-APPc+Fe65Y546F+c-AblXB,"

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "; GAL4-APPc+Fe65+c-AblXB"

Phrase: "versus"

Phrase: "GAL4-APPc+Fe65Y547F+c-AblXB,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.199: Mutant GAL4-APPcY682F stimulates GAL4-APPc/Fe65 transcription in both the presence or absence of c-AblXB (p < 0.05, absence of c-AblXB; p < 0.05, presence of c-AblXB). 

Phrase: "Mutant GAL4-APPcY682F"

Phrase: "stimulates"

Phrase: "GAL4-APPc/Fe65 transcription in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040649:Transcription [Genetic Function]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(p < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "absence of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "; p < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "presence of c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.200: B, similar experiment using full-length APP into which the GAL4 DNA binding domain has been engineered (GAL4-APP). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "similar experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "full-length APP into which"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "the GAL4 DNA binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "(GAL4-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.201: c-AblXB again stimulates GAL4-APP/Fe65 transcription, and this effect is abolished by mutant Fe65Y547F but not Fe65Y546F (GAL4-APP+Fe65+c-AblXB versus GAL4-APP+Fe65Y546F+c-AblXB, no significant difference; GAL4-APP+Fe65+c-AblXB versus GAL4-APP+Fe65Y547F+c-AblXB, p < 0.001). 

Phrase: "c-AblXB again"

Phrase: "stimulates"

Phrase: "GAL4-APP/Fe65 transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "abolished by mutant Fe65Y547F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "not Fe65Y546F"

Phrase: "(GAL4-APP+Fe65+c-AblXB"

Phrase: "versus"

Phrase: "GAL4-APP+Fe65Y546F+c-AblXB,"

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "; GAL4-APP+Fe65+c-AblXB"

Phrase: "versus"

Phrase: "GAL4-APP+Fe65Y547F+c-AblXB,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.202: Results shown are from 12 (A) or 16 (B) transfections; 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are from 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "(A)"

Phrase: "or"

Phrase: "16"

Phrase: "(B) transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: ";"
Processing 00000000.tx.203: error bars are S.E.  

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "are S.E."
Processing 00000000.tx.204: We next tested whether the stimulatory effect of c-AblXB on APP/Fe65 transcription was through phosphorylation of Fe65Tyr-547. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65 transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "was through phosphorylation of Fe65Tyr-547."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.205: Mutation of this residue to phenylalanine to preclude phosphorylation (Fe65Y547F) completely eliminated the effect of c-AblXB (Fig. 4A). 

Phrase: "Mutation of this residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to phenylalanine to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "preclude"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fe65Y547F"

Phrase: ")"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.206: However, Fe65Y547F was still capable of stimulating GAL4-APPc-dependent transcription (Fig. 4A). 

Phrase: "However,"

Phrase: "Fe65Y547F"

Phrase: "was"

Phrase: "still capable of stimulating GAL4-APPc-dependent transcription"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.207: This latter observation suggests that a component of the Fe65 stimulatory effect on GAL4-APPc-mediated transcription is not dependent upon phosphorylation of Fe65Tyr-547. 

Phrase: "This latter observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a component of the Fe65 stimulatory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "on GAL4-APPc-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "not dependent upon phosphorylation of Fe65Tyr-547."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.208: It also suggests that mutation of Fe65Tyr-547 to phenylalanine does not induce some conformational change to this domain of the protein that precludes the ability of Fe65 to stimulate transcription from GAL4-APPc. 

Phrase: "It also"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mutation of Fe65Tyr-547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "some conformational change to this domain of the protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0301641:Conformational change [Molecular Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "precludes"

Phrase: "the ability of Fe65 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "transcription from GAL4-APPc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.209: This was further confirmed by monitoring the effect of mutating the adjacent tyrosine (Fe65Tyr-546) to phenylalanine (Fe65Y546F). 

Phrase: "This"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed by monitoring"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0150369:Monitoring [Health Care Activity]
   790   C0750484:Confirmed [Idea or Concept]
   790   C1516647:monitoring [Research Activity]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "the effect of mutating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the adjacent tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Fe65Tyr-546"

Phrase: ")"

Phrase: "to phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Fe65Y546F"

Phrase: ")."
Processing 00000000.tx.210: This mutant behaved in a similar fashion to wild-type Fe65 (Fig. 4A). 

Phrase: "This mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "behaved in a similar fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "to wild-type Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412459:FE65 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.211: We also tested whether mutation of Fe65Tyr-547 inhibited transcription from full-length GAL4-APP and obtained similar results to GAL4-APPc (Fig. 4B). 

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "mutation of Fe65Tyr-547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "transcription from full-length GAL4-APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "obtained similar results to GAL4-APPc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: Thus, the stimulatory effect of c-AblXB on APP/Fe65 transcription is through phosphorylation of Fe65Tyr-547. 

Phrase: "Thus,"

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65 transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is through phosphorylation of Fe65Tyr-547."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.213: Tyrosine 547 resides within the second PTB domain of Fe65 and because this domain binds APP, it is possible that its phosphorylation influences Fe65-APP interactions in some manner. 

Phrase: "Tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "resides within the second PTB domain of Fe65"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   764   C1323325:phosphotyrosine binding [Molecular Function]
   742   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205436:Second [Quantitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0457385:Second [Temporal Concept]
   742   C0565930:/second [Quantitative Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1412459:FE65 [Gene or Genome]
   742   C1561503:second [Idea or Concept]
   742   C1705190:Second [Qualitative Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C2982691:Reside [Activity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "because"

Phrase: "this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "its phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "influences"

Phrase: "Fe65-APP interactions in some manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   711   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.214: We therefore performed immunoprecipitation assays to determine whether c-AblXB altered binding of APP and GAL4-APPc to Fe65. 

Phrase: "We therefore performed immunoprecipitation assays to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "determine"

Phrase: "whether"

Phrase: "c-AblXB"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "GAL4-APPc to Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0052145:APPC [Antibiotic,Organic Chemical]
Processing 00000000.tx.215: Fe65 isolated from Fe65+APP- or Fe65+APP+c-AblXB-transfected cells bound identical amounts of APP (Fig. 5A). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "isolated from Fe65+APP-"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205409:Isolated [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1412459:FE65 [Gene or Genome]
   753   C1548221:Isolated [Idea or Concept]
   753   C1709634:Precursor [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "Fe65+APP+c-AblXB-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C0018956:precursor cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "identical amounts of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.216: Likewise, the presence of c-AblXB did not influence the amounts of GAL4-APPc bound to Fe65 (Fig. 5B). 

Phrase: "Likewise,"

Phrase: "the presence of c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the amounts of GAL4-APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "bound to Fe65"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1412459:FE65 [Gene or Genome]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.217: To determine whether c-AblXB influenced binding of APP to endogenous Fe65, we immunoprecipitated APP from APP- or APP+c-AblXB-transfected cells and probed for bound Fe65. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "c-AblXB"

Phrase: "influenced"

Phrase: "binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to endogenous Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "we"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "APP from APP-"

Phrase: "or"

Phrase: "APP+c-AblXB-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   860   C0018956:precursor cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "probed for bound Fe65."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1412459:FE65 [Gene or Genome]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.218: However, we again could detect no differences in the amounts of co-immunoprecipitating Fe65 (Fig. 5C). 

Phrase: "However,"

Phrase: "we again"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "no differences in the amounts of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "co-immunoprecipitating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.219: We also probed these samples with antibody 4G10, and this demonstrated that at least a proportion of Fe65 that was bound to APP was tyrosine-phosphorylated. 

Phrase: "We also"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "these samples with antibody 4G10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "this"

Phrase: "demonstrated"

Phrase: "that at least"

Phrase: "a proportion of Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "bound to APP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0522527:Protein bound [Qualitative Concept]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332297:bound [Spatial Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1709634:Precursor [Idea or Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "tyrosine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated."
Processing 00000000.tx.220: View larger version (55K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.221: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.222: Neither c-AblXB nor mutation of either Fe65Y547F or APPY682F alters APP-Fe65 interactions. 

Phrase: "Neither c-AblXB"

Phrase: "nor"

Phrase: "mutation of either Fe65Y547F"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "APPY682F"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP-Fe65 interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   836   C0872079:protein interaction [Molecular Function]
   771   C1704675:Interaction [Functional Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.223: A, equal amounts of APP in Fe65 immunoprecipitates from Fe65+APP- and Fe65+APP+ c-AblXB-transfected cells. 

Phrase: "A,"

Phrase: "equal amounts of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "in Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "immunoprecipitates from Fe65+APP-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0301871:Immunoprecipitate [Immunologic Factor]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1412459:FE65 [Gene or Genome]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Fe65+APP+ c-AblXB-transfected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C0018956:precursor cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.224: B, similar experiment from Fe65+GAL4-APPc- and Fe65+GAL4-APPc+c-AblXB-transfected cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "similar experiment from Fe65+GAL4-APPc-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0681814:Experiment [Research Activity]
   753   C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "Fe65+GAL4-APPc+c-AblXB-transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.225: In both A and B, Fe65 was immunoprecipitated using the Myc tag and coimmunoprecipitated APP/GAL4-APPc and c-AblXB were detected with APPab and c-Abl antibodies, respectively. 

Phrase: "In both"

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Myc tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "coimmunoprecipitated APP/GAL4-APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "were"

Phrase: "detected with APPab"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "c-Abl antibodies,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   896   C0368815:C ANTIBODY [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896   C1963095:c Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0079050:c abl [Gene or Genome]
   734   C1412097:c-ABL [Gene or Genome]
   734   C1704928:c-Abl [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.226: Fe65 was detected using a polyclonal antibody. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a polyclonal antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.227: C, equal amounts of endogenous Fe65 bound to APP in APP- and APP+c-AblXB-transfected CHO cells. 

Phrase: "C,"

Phrase: "equal amounts of endogenous Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "bound to APP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0522527:Protein bound [Qualitative Concept]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332297:bound [Spatial Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1709634:Precursor [Idea or Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "in APP-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APP+c-AblXB-transfected CHO cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0018956:precursor cell [Cell]
   812   C0085080:CHO Cells [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.228: APP was immunoprecipitated and detected with antibody 22C11 and coimmunoprecipitated Fe65 and c-AblXB detected as above; 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "detected with antibody 22C11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "coimmunoprecipitated Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "detected as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.229: tyrosine-phosphorylated Fe65 in the APP immunoprecipitates was detected with antibody 4G10. 

Phrase: "tyrosine-phosphorylated Fe65 in the APP immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "detected with antibody 4G10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.230: D, equal amounts of APP in Fe65 immunoprecipitates from Fe65+APP-, Fe65Y546F+APP (Fe65Y546F+APP)-, Fe65Y547F+APP (Fe65Y547F+APP)-, and Fe65+APPY682F (Fe65+APPY682F)-transfected cells. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "equal amounts of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "in Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "immunoprecipitates from Fe65+APP-,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0301871:Immunoprecipitate [Immunologic Factor]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1412459:FE65 [Gene or Genome]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "Fe65Y546F+APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(Fe65Y546F+APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")-"

Phrase: ","

Phrase: "Fe65Y547F+APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(Fe65Y547F+APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")-"

Phrase: ","

Phrase: "and"

Phrase: "Fe65+APPY682F"

Phrase: "(Fe65+APPY682F"

Phrase: ")-"

Phrase: "transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.231: Fe65 and APP were immunoprecipitated and detected as in A and B. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "as in A"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.232: (+) and (-) refer to the presence or absence of immunoprecipitating antibodies in the assays.  

Phrase: "(+"

Phrase: ")"

Phrase: "and (-)"

Phrase: "refer to the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205543:refer [Functional Concept]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of immunoprecipitating antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.233: We next tested whether the Fe65Y547F and APPY682F mutations altered binding of APP and Fe65, respectively, in immunoprecipitation experiments. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "the Fe65Y547F"

Phrase: "and"

Phrase: "APPY682F mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "binding of APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "respectively,"

Phrase: "in immunoprecipitation experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.234: However, neither of these mutants had altered binding properties (Fig. 5D). 

Phrase: "However,"

Phrase: "neither of these mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   770   C3274651:Neither [Qualitative Concept]

Phrase: "had"

Phrase: "altered binding properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.235: Mutant APPY682F has previously been shown to bind Fe65 (43). 

Phrase: "Mutant APPY682F"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.236: Thus, c-AblXB phosphorylates Fe65 within its second PTB domain to stimulate APP/Fe65 transcriptional activity, but this stimulation does not appear to be through an overt effect on Fe65/APP interactions. 

Phrase: "Thus,"

Phrase: "c-AblXB"

Phrase: "phosphorylates"

Phrase: "Fe65 within its second PTB domain to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1412459:FE65 [Gene or Genome]

Phrase: "stimulate"

Phrase: "APP/Fe65 transcriptional activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   898   C1325278:amyloid protein activity [Molecular Function]
   858   C1537044:protein activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "this stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be through an overt effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "on Fe65/APP interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   823   C0872079:protein interaction [Molecular Function]
   771   C1704675:Interaction [Functional Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.237: Recently, APPc has been shown to induce expression of the GSK3 gene (44). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of the GSK3 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.238: We therefore asked whether c-AblXB stimulated the APPc-dependent expression of GSK3 by analyzing GSK3 protein levels in cells transfected with APPc either alone or with Fe65 and c-AblXB using immunoblotting techniques. 

Phrase: "We therefore"

Phrase: "asked"

Phrase: "whether"

Phrase: "c-AblXB"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the APPc-dependent expression of GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by analyzing GSK3 protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "c-AblXB"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunoblotting techniques."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020985:Immunoblotting [Laboratory Procedure]
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.239: Because we obtain 3040% transfection efficiencies, any changes observed in these pooled samples of transfected and non-transfected cells are likely to be less than that seen in individual transfected cells. 

Phrase: "Because"

Phrase: "we"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "3040% transfection efficiencies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0013682:efficiencies [Quantitative Concept]
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   743 E C0442799:Efficient [Qualitative Concept]

Phrase: "any changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "observed in these pooled samples of transfected"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   762   C1709595:Pooled Sample [Conceptual Entity]
           Pooled
   748   C1441672:Observed [Functional Concept]
   748   C2349200:Pooled [Functional Concept]
   741 E C1509144:Sample pool [Clinical Attribute]
       E   pool
   714 E C0337051:Pool [Geographic Area]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "non-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "less than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: "seen in individual transfected cells."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0027361:Individual [Population Group]
   760   C0205397:Seen [Qualitative Concept]
   760   C0237401:Individual [Human]
   760   C3282337:Cells [Cell]
   726 E C0042789:see [Organism Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1947903:See [Activity]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.240: Nevertheless, although we observed little change to GSK3 protein levels following co-transfection of APPc with Fe65 or c-AblXB alone, we detected a marked increase in GSK3 signal in cells transfected with all three plasmids (Fig. 6A). 

Phrase: "Nevertheless,"

Phrase: "although"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "little change to GSK3 protein levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "co-transfection of APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "or"

Phrase: "c-AblXB"

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a marked increase in GSK3 signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with all three plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205449:Three [Quantitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.241: We also studied the effect of c-AblXB on GSK3 protein levels by immunostaining, and this revealed that transfection of APPc+Fe65+c-AblXB increased the GSK3 signal compared with non-transfected cells (Fig. 6B). 

Phrase: "We also"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on GSK3 protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "by immunostaining,"

Phrase: "and"

Phrase: "this"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that transfection of APPc+Fe65+c-AblXB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the GSK3 signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "compared with non-transfected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C1518422:Non [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.242: View larger version (43K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.243: 6. 

Phrase: "6."
Processing 00000000.tx.244: c-AblXB stimulates APPc-dependent expression of GSK3 in transfected CHO cells. 

Phrase: "c-AblXB"

Phrase: "stimulates"

Phrase: "APPc-dependent expression of GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transfected CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.245: A, immunoblots of cells transfected with empty vector or APPc either alone or with Fe65, c-AblXB, or Fe65+c-AblXB as indicated. 

Phrase: "A,"

Phrase: "immunoblots of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "transfected with empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "or"

Phrase: "APPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or with Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412459:FE65 [Gene or Genome]

Phrase: "c-AblXB,"

Phrase: "or"

Phrase: "Fe65+c-AblXB"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.246: The blots were also probed for tubulin to demonstrate equal loading. 

Phrase: "The blots"

Phrase: "were"

Phrase: "also"

Phrase: "probed for tubulin to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2937342:tubulin [Cell Component]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "demonstrate"

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.247: B, immunofluorescent labeling of CHO cells transfected with APPc+Fe65+c-AblXB and double-labeled for GSK3 and c-Abl as indicated. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "immunofluorescent labeling of CHO cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "transfected with APPc+Fe65+c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0052145:APPC [Antibiotic,Organic Chemical]
   753   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "-"

Phrase: "labeled for GSK3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.248: Scale bar is 10 m.   

Phrase: "Scale bar"

Phrase: "is"

Phrase: "10 m."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.249: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The functions of APP are not properly understood. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The functions of APP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "not properly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.250: However, several recent studies have demonstrated that the C-terminal domain of APP, produced by -secretase activity, can translocate to the nucleus to regulate transcriptional events (1924, 43, 45, 46). 

Phrase: "However,"

Phrase: "several recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the C-terminal domain of APP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "produced by -secretase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "translocate to the nucleus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007610:Nucleus [Cell Component]

Phrase: "regulate"

Phrase: "transcriptional events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "(1924,"

Phrase: "43,"

Phrase: "45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.251: One APP binding partner that is involved in this process is the adaptor protein Fe65 (19, 2124, 43). 

Phrase: "One APP binding partner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0033618:Protein Binding [Molecular Function]
   799   C0243122:binding [Functional Concept]
   799   C0682323:Partner [Family Group]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "is"

Phrase: "involved in this process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "the adaptor protein Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412459:FE65 [Gene or Genome]
   734   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(19,"

Phrase: "2124,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.252: Fe65 is present within the nucleus and, aside from APP, binds to at least two transcription factors, CP2/LSF/LBP1 and Tip60 (19, 25). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "present within the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "aside from APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to at least two transcription factors,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0040649:Transcription [Genetic Function]
   753   C0205448:Two [Quantitative Concept]
   753   C1883351:To [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "CP2/LSF/LBP1"

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(19,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.253: The Fe65WW domain is required for its stimulatory effect on APP-mediated transcription (19) and also for nuclear translocation of Fe65 (28). 

Phrase: "The Fe65WW domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for its stimulatory effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1280500:Effect [Qualitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-mediated transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(19"

Phrase: ")"

Phrase: "and"

Phrase: "also for nuclear translocation of Fe65"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1518440:Nuclear Translocation [Molecular Function]
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1412459:FE65 [Gene or Genome]
   753   C2987521:Translocation [Activity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.254: This suggests that WW domain ligands are required for the nuclear functions of Fe65. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that WW domain ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligands [Chemical]

Phrase: "are"

Phrase: "required for the nuclear functions of Fe65."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0521447:Nuclear [Spatial Concept]
   748   C0542341:Functions [Functional Concept]
   748   C1412459:FE65 [Gene or Genome]
   748   C1514873:Required [Functional Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.255: One Fe65WW domain ligand is the tyrosine kinase c-Abl (25). 

Phrase: "One Fe65WW domain ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023688:Ligand [Chemical]

Phrase: "is"

Phrase: "the tyrosine kinase c-Abl (25"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C1704928:ABL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.256: c-Abl phosphorylates APP on tyrosine 682 (25) and here, we demonstrate that it additionally phosphorylates Fe65 on tyrosine 547. 

Phrase: "c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "phosphorylates"

Phrase: "APP on tyrosine 682"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "here,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "it additionally"

Phrase: "phosphorylates"

Phrase: "Fe65 on tyrosine 547."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.257: We also show that active c-Abl stimulates APP/Fe65-mediated transcription and that this is through phosphorylation of Fe65Tyr-547 but not APPTyr-682. 

Phrase: "We also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that active c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "stimulates"

Phrase: "APP/Fe65-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "is through phosphorylation of Fe65Tyr-547"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "but"

Phrase: "not APPTyr-682."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]
Processing 00000000.tx.258: Tyrosine phosphorylation of the C-terminal domain of APP does not influence APP binding to Fe65, although it can modulate interactions with ShcA and disabled, two other PTB domain proteins (5, 10, 14, 47). 

Phrase: "Tyrosine phosphorylation of the C-terminal domain of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1519726:Tyrosine Phosphorylation [Molecular Function]
   754   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   738   C0031715:Phosphorylation [Molecular Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "APP binding to Fe65,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0033618:Protein Binding [Molecular Function]
   783 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "although"

Phrase: "it"

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "interactions with ShcA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "disabled, two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "other PTB domain proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "14,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.259: The residue within Fe65 that is phosphorylated by active c-Abl (tyrosine 547) resides within the second PTB domain, and this domain binds to APP. 

Phrase: "The residue within Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "phosphorylated by active c-Abl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205177:Active [Functional Concept]
   760   C1704928:ABL [Gene or Genome]

Phrase: "(tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "resides within the second PTB domain,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   778   C1323325:phosphotyrosine binding [Molecular Function]
   748   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205436:Second [Quantitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C2982691:Reside [Activity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "binds to APP."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.260: However, Fe65 and Fe65Y547F (which cannot be phosphorylated) both bound APP equally well in immunoprecipitation experiments, and we could detect no changes in Fe65/APP or Fe65/APPc-GAL4 interactions in cells co-transfected with c-AblXB. 

Phrase: "However,"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Fe65Y547F"

Phrase: "("

Phrase: "which"

Phrase: "cannot"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: ")"

Phrase: "both bound APP equally well in immunoprecipitation experiments,"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0522527:Protein bound [Qualitative Concept]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0021069:Immunoprecipitation [Laboratory Procedure]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205170:Well [Qualitative Concept]
   739   C0238767:Both [Spatial Concept]
   739   C0332297:bound [Spatial Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0681814:Experiments [Research Activity]
   739   C1145667:Bound [Activity]
   739   C1167622:Bound [Molecular Function]
   739   C1689898:% bound [Quantitative Concept]
   739   C1706086:Both [Qualitative Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C2349209:Bound [Conceptual Entity]
   739   C3146287:Well [Manufactured Object]
   706 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "we"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "no changes in Fe65/APP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   762   C0442739:No change [Finding]
   762   C1548568:No change [Intellectual Product]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "Fe65/APPc-GAL4 interactions in cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0007582:Interactions, Cell [Cell Function]
   719   C1704675:Interaction [Functional Concept]

Phrase: "co-transfected with c-AblXB."
Processing 00000000.tx.261: As such, phosphorylation of APPTyr-682 or Fe65Tyr-547 by active c-Abl appears not to influence APP/Fe65 interactions in any overt manner. 

Phrase: "As"

Phrase: "such,"

Phrase: "phosphorylation of APPTyr-682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "Fe65Tyr-547 by active c-Abl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205177:Active [Functional Concept]
   753   C1704928:ABL [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "APP/Fe65 interactions in any overt manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0872079:interactions protein [Molecular Function]
   708   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.262: Thus, while the stimulatory effect of c-AblXB on APP/Fe65 transcription is mediated by Fe65Tyr-547 phosphorylation, this does not involve any marked changes in binding of APP to Fe65. 

Phrase: "Thus,"

Phrase: "while"

Phrase: "the stimulatory effect of c-AblXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP/Fe65 transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040649:Transcription [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is"

Phrase: "mediated by Fe65Tyr-547 phosphorylation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "any marked changes in binding of APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "to Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.263: Platelet-derived growth factor has recently been shown to induce ,-secretase cleavage of APP and this was characterized by monitoring the transcriptional activity of an APP-GAL4 fusion gene similar to the ones we used here (38). 

Phrase: "Platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: ",-"

Phrase: "secretase cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "this"

Phrase: "was"

Phrase: "characterized by monitoring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0150369:Monitoring [Health Care Activity]
   790   C1516647:monitoring [Research Activity]
   790   C1880022:Characterized [Activity]

Phrase: "the transcriptional activity of an APP-GAL4 fusion gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1325278:amyloid protein activity [Molecular Function]
   754   C1537044:protein activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "similar to the ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.264: In the course of this study, active c-Abl was shown to have no effect on APP-GAL4-mediated transcription (38). 

Phrase: "In the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "active c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "no effect on APP-GAL4-mediated transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.265: However, the APP-GAL4 fusion used in this earlier work comprised full-length GAL4 (containing both its DNA binding and transactivation domains) such that while transcription of the reporter gene required APP cleavage, it did not require the transactivation capability of the APP C-terminal domain. 

Phrase: "However,"

Phrase: "the APP-GAL4 fusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "used in this earlier"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1279919:Early [Temporal Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "comprised full-length GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1416832:GAL4 [Gene or Genome]

Phrase: "("

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both its DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148673:DNA Binding [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "transactivation domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040624:Transactivation [Genetic Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "such"

Phrase: "that"

Phrase: "while"

Phrase: "transcription of the reporter gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "APP cleavage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0597304:Protein Cleavage [Molecular Function]
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "the transactivation capability of the APP C-terminal domain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2698977:Capability [Qualitative Concept]
Processing 00000000.tx.266: In contrast, our GAL4-APP and GAL4-APPc fusions involve only the GAL4 DNA binding domain, and the APP C-terminal domain is thus essential for transcriptional activity (see also Ref. 19). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "our GAL4-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "GAL4-APPc fusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332466:fusions [Functional Concept]
   827   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "involve"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the GAL4 DNA binding domain,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the APP C-terminal domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0162808:Protein Domain [Spatial Concept]
   858   C1514562:Protein Domain [Amino Acid Sequence]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "thus essential for transcriptional activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also Ref. 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.267: Thus, these different findings are most probably the result of the different GAL4-APP fusions used in these two studies. 

Phrase: "Thus,"

Phrase: "these different findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "most probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0750492:Probably [Idea or Concept]

Phrase: "the result of the different GAL4-APP fusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "used in these two studies."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   781   C0869040:Use studies [Research Activity]
   760   C0205448:Two [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.268: Indeed, the earlier work of Gianni et al. 

Phrase: "Indeed,"

Phrase: "the earlier work of Gianni et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0043227:Work [Occupational Activity]
Processing 00000000.tx.269: (38) was an elegant study aimed at understanding the mechanisms regulating APP cleavage and not APP/Fe65-mediated transcription as in our work. 

Phrase: "(38"

Phrase: ")"

Phrase: "was"

Phrase: "an elegant study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "aimed at understanding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162340:Understanding [Mental Process]
   756   C1947946:Aim [Idea or Concept]
   756   C2948600:Aim [Pharmacologic Substance]
   756   C3540471:AIM [Gene or Genome]
   756   C3540472:AIM [Functional Concept]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "APP cleavage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0597304:Protein Cleavage [Molecular Function]
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "not APP/Fe65-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0040649:Transcription [Genetic Function]

Phrase: "as in our work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.270: Nevertheless, we tested whether c-AblXB also stimulated reporter gene activity that was driven by an APP-GAL4 DNA binding domain fusion in which GAL4 DNA binding domain sequences were fused to the C terminus of APP (APP-GAL4). 

Phrase: "Nevertheless,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "c-AblXB also stimulated reporter gene activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "was"

Phrase: "driven by an APP-GAL4 DNA binding domain fusion"
Meta Candidates (Total=32; Excluded=0; Pruned=0; Remaining=32)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C1511662:DNA Binding Domain [Amino Acid Sequence]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   772   C0012940:DNA Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   772   C0812382:DNA-binding protein [Gene or Genome]
   772   C1514535:Protein Binding Domain [Amino Acid Sequence]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1148673:DNA Binding [Genetic Function]
   754   C0033618:Protein Binding [Molecular Function]
   754   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   754   C0162808:Protein Domain [Spatial Concept]
   754   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0682990:DNA precursor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C1514562:Protein Domain [Amino Acid Sequence]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0243122:binding [Functional Concept]
   738   C0332466:Fusion [Functional Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1293131:Fusion [Therapeutic or Preventive Procedure]
   738   C1416832:GAL4 [Gene or Genome]
   738   C1709634:Precursor [Idea or Concept]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]
   704   C0013126:Drive [Mental Process]

Phrase: "in which GAL4 DNA binding domain sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   875   C0162326:DNA Sequences [Nucleotide Sequence]
           Sequences
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]
   717   C1511662:DNA Binding Domain [Amino Acid Sequence]

Phrase: "were"

Phrase: "fused to the C terminus of APP"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0699952:Fused [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
   708 E C1414861:FUSE [Gene or Genome]
   708 E C1708111:Fuse [Manufactured Object]

Phrase: "(APP-GAL4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1416832:GAL4 [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.271: c-AblXB also stimulated transcription from this fusion protein (APP-GAL4 versus APP-GAL4+c-AblXB transcription, 1:1.65; 

Phrase: "c-AblXB also stimulated transcription from this fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040649:Transcription [Genetic Function]

Phrase: "(APP-GAL4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1416832:GAL4 [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "versus"

Phrase: "APP-GAL4+c-AblXB transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0040649:Transcription [Genetic Function]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1.65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450385:65 [Intellectual Product]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.272: p < 0.001). 

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.273: The precise mechanisms by which phosphorylation of Fe65 by c-Abl stimulates its transcriptional activity are not clear. 

Phrase: "The precise mechanisms by which phosphorylation of Fe65"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "by c-Abl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079050:c abl [Gene or Genome]
  1000   C1412097:c-ABL [Gene or Genome]
  1000   C1704928:c-Abl [Gene or Genome]
           ABL
   861   C1553033:[c] [Quantitative Concept]

Phrase: "stimulates"

Phrase: "its transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.274: Because the phosphorylated residue (tyrosine 547) is within the second Fe65 PTB domain, we initially anticipated that it might influence Fe65/APP interactions in some manner. 

Phrase: "Because"

Phrase: "the phosphorylated residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "(tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "is within the second Fe65 PTB domain,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   770   C1323325:phosphotyrosine binding [Molecular Function]
   744   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205436:Second [Quantitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C0457385:Second [Temporal Concept]
   744   C0565930:/second [Quantitative Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1412459:FE65 [Gene or Genome]
   744   C1561503:second [Idea or Concept]
   744   C1705190:Second [Qualitative Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "we initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "anticipated"

Phrase: "that"

Phrase: "it"

Phrase: "might"

Phrase: "influence"

Phrase: "Fe65/APP interactions in some manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   711   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.275: However, our immunoprecipitation assays have not provided experimental evidence to support this notion. 

Phrase: "However,"

Phrase: "our immunoprecipitation assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "experimental evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this notion."
Processing 00000000.tx.276: Nevertheless, it remains likely that phosphorylation of Fe65 (and perhaps APP) by c-Abl somehow alters the various protein-protein interactions of the Fe65/APP transcriptional complex. 

Phrase: "Nevertheless,"

Phrase: "it"

Phrase: "remains"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that phosphorylation of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "("

Phrase: "and"

Phrase: "perhaps APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "by c-Abl somehow"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0079050:c abl [Gene or Genome]
   901   C1412097:c-ABL [Gene or Genome]
   901   C1704928:c-Abl [Gene or Genome]
           ABL
   827   C1553033:[c] [Quantitative Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the various protein-protein interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   890   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C1704675:Interaction [Functional Concept]

Phrase: "of the Fe65/APP transcriptional complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C1523872:protein complex [Cell Component]
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.277: One way to gain insight into this would be to solve the structure of non-phosphorylated and phosphorylated Fe65 bound to the C terminus of APP. 

Phrase: "One way to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233820:Insight [Mental Process]

Phrase: "would"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "solve"

Phrase: "the structure of non-phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "phosphorylated Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "bound to the C terminus of APP."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0522527:Protein bound [Qualitative Concept]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332297:bound [Spatial Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1689898:% bound [Quantitative Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.278: Tyrosine 547 is located toward the N terminus of the Fe65 PTB domain and falls within the motif Tyr-Leu-Gly. 

Phrase: "Tyrosine 547"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "located toward the N terminus of the Fe65 PTB domain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   775   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   756   C1323325:phosphotyrosine binding [Molecular Function]
   738   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1412459:FE65 [Gene or Genome]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "falls within the motif Tyr-Leu-Gly."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0125601:Leu-Gly [Amino Acid, Peptide, or Protein]
   778   C0614361:Tyr-Leu [Amino Acid, Peptide, or Protein]
   774 E C0061736:Gly-Leu [Amino Acid, Peptide, or Protein]
   748   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0085639:Fall [Finding]
   748   C0238715:Fall [Temporal Concept]
   748   C1421250:TYR [Gene or Genome]
   748   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.279: This motif is conserved in a number of other PTB-bearing proteins including Fe65like-1 and like-2 (Fe65like-2 contains the motif Tyr-Met-Gly), X11, X11, Shc, and Numb. 

Phrase: "This motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "conserved in a number of other PTB-bearing proteins"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C1323325:phosphotyrosine binding [Molecular Function]
   757   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0033618:Protein Binding [Molecular Function]
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0237753:*Number [Quantitative Concept]
   739   C0243122:binding [Functional Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1704689:Bearing [Medical Device]
   706 E C0004897:Bear [Mammal]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Fe65like-1"

Phrase: "and like-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(Fe65like-2"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the motif Tyr-Met-Gly),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0387019:Met-Gly [Amino Acid, Peptide, or Protein]
   812   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "X11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "X11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "Shc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705297:SHC [Gene or Genome]

Phrase: "and"

Phrase: "Numb."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417890:NUMB [Gene or Genome]
  1000   C1709287:Numb [Individual Behavior]
Processing 00000000.tx.280: We are unaware of any report describing phosphorylation of the homologous tyrosine in these other PTB domain proteins. 

Phrase: "We"

Phrase: "are"

Phrase: "unaware of any report describing phosphorylation of the homologous tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0150114:UNAWARE [Research Activity]

Phrase: "in these"

Phrase: "other PTB domain proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
Processing 00000000.tx.281: However, our finding that the Fe65 PTB domain is phosphorylated raises the possibility that these other proteins may also be tyrosine-phosphorylated on their PTB domains. 

Phrase: "However,"

Phrase: "our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the Fe65 PTB domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that"

Phrase: "these other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "tyrosine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated on their PTB domains."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   822   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   790   C1323325:phosphotyrosine binding [Molecular Function]
   753   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.282: Tyrosine phosphorylation of PTB domains might therefore be a novel mechanism for regulating the function of this class of protein. 

Phrase: "Tyrosine phosphorylation of PTB domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "might"

Phrase: "therefore"

Phrase: "be"

Phrase: "a novel mechanism for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "the function of this class of protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0815043:function protein [Amino Acid, Peptide, or Protein]
   774   C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
Processing 00000000.tx.283: Mis-metabolism of APP is believed to be central to the pathogenesis of Alzheimer's disease. 

Phrase: "Mis-metabolism of APP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   864   C1327340:amyloid precursor protein metabolism [Molecular Function]
   783   C0597299:Protein Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0687670:MIS [Amino Acid, Peptide, or Protein,Hormone]
   753   C1333208:MIS [Gene or Genome]
   753   C1412384:MIS [Gene or Genome]
   753   C3538735:MIS [Gene or Genome]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "central to the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205099:Central [Spatial Concept]
   748   C1879652:Central - [Laboratory Procedure]
Processing 00000000.tx.284: Altered APP processing leading to increased production of A is one favored pathogenic event but such changes are also likely to influence APP/Fe65 nuclear signaling, and this too may contribute to the neurodegenerative process (48). 

Phrase: "Altered APP processing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "leading to increased production of A"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0861064:increased lead [Finding]
   753   C0033268:production [Occupational Activity]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "favored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "pathogenic event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "but"

Phrase: "such changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "also likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "influence"

Phrase: "APP/Fe65 nuclear signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "this too"

Phrase: "may"

Phrase: "contribute to the neurodegenerative process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]
   760   C1880177:Contribute [Activity]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.285: Indeed, familial Alzheimer's disease mutant presenilin-1 has recently been shown to have altered nuclear signaling function and this has been causally related to familial forms of Alzheimer' s disease (49). 

Phrase: "Indeed,"

Phrase: "familial Alzheimer's disease mutant presenilin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C2931257:Alzheimer disease 1 [Disease or Syndrome]
   830   C1425075:MALS-1 [Gene or Genome]
   827   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PRESENILIN 1 [Gene or Genome]
   799   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "altered nuclear signaling function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "causally"

Phrase: "related to familial forms of Alzheimer' s disease"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   804   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   762   C1832428:Familial form [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   738 E C0344339:disease family [Finding]
   714 E C0163712:Relate [Organic Chemical]
   714 E C1522492:Form [Functional Concept]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.286: Thus, defective phosphorylation of Fe65 by active c-Abl may alter APP/Fe65 nuclear signaling, and this might also contribute to Alzheimer's disease.  

Phrase: "Thus,"

Phrase: "defective phosphorylation of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "by active c-Abl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704928:ABL [Gene or Genome]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP/Fe65 nuclear signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "this"

Phrase: "might"

Phrase: "also"

Phrase: "contribute to Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.287: FOOTNOTES  * This work was supported by grants from the Medical Research Council, Wellcome Trust, European Union Vth Framework, and Research into Aging. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Medical Research Council,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "Wellcome Trust,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237935:Trust [Individual Behavior]
   861   C3245466:trust [Idea or Concept]

Phrase: "European Union Vth Framework,"

Phrase: "and"

Phrase: "Research into Aging."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035168:research [Research Activity]
   790   C0242481:Research [Research Activity]
Processing 00000000.tx.288: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.289: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.290: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.291: || To whom correspondence should be addressed: Dept. of Neuroscience, P. 

Phrase: "||"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.292: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.293: Box PO37, The Institute of Psychiatry, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. 

Phrase: "Box PO37,"

Phrase: "The Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "King's College London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023973:London [Geographic Area]

Phrase: "De Crespigny Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "Denmark Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "London SE5 8AF,"

Phrase: "UK."
Processing 00000000.tx.294: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.295: 44-0-2078480393; 

Phrase: "44-0-2078480393"

Phrase: ";"
Processing 00000000.tx.296: Fax: 44-0-2077080017; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "44-0-2077080017"

Phrase: ";"
Processing 00000000.tx.297: E-mail: chris.miller{at}iop.kcl.ac.uk . 1 The abbreviations used are: APP, amyloid precursor protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "chris.miller{at}iop.kcl.ac.uk . 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0219333:UK 1 [Organic Chemical,Pharmacologic Substance]
   793   C0402830:Miller [Professional or Occupational Group]
   793   C1412573:AC [Gene or Genome]
   793   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   793   C3539770:AC [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.298: GSK3, glycogen synthase kinase-3; 

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.299: CHO, Chinese hamster ovary; 

Phrase: "CHO,"

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.300: GST, glutathione S-transferase; 

Phrase: "GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.301: PTB, phosphotyrosine binding; 

Phrase: "PTB,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1323325:phosphotyrosine binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "phosphotyrosine binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1323325:phosphotyrosine binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.302: APPc, the C-terminal domain of APP.  

Phrase: "APPc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052145:APPC [Antibiotic,Organic Chemical]

Phrase: "the C-terminal domain of APP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.303: ACKNOWLEDGMENTS  We thank Thomas Sudhof (University of Texas, Dallas) and Richard Van Etten (Harvard University, Boston) for GAL4-APP and c-Abl plasmids, respectively.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Thomas Sudhof"

Phrase: "(University of Texas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039711:Texas [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Dallas"

Phrase: ")"

Phrase: "and"

Phrase: "Richard Van Etten"

Phrase: "(Harvard University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Boston"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: ")"

Phrase: "for GAL4-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "c-Abl plasmids,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0079050:c abl [Gene or Genome]
   734   C1412097:c-ABL [Gene or Genome]
   734   C1704928:c-Abl [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.304: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  De Strooper, B., and Annaert, W. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Annaert,"

Phrase: "W."
Processing 00000000.tx.305: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.306: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.307: 113, 1857-1870[Abstract/Free FullText] Fiore, F., Zambrano, N., Minopoli, G., Donini, V., Duilio, A., and Russo, T. 

Phrase: "113,"

Phrase: "1857-1870"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fiore,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Donini,"

Phrase: "V.,"

Phrase: "Duilio,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.308: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.309: Biol. 

Phrase: "Biol."
Processing 00000000.tx.310: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.311: 270, 30853-30856[Abstract/Free FullText] McLoughlin, D. 

Phrase: "270,"

Phrase: "30853-30856"

Phrase: "[Abstract/Free FullText"

Phrase: "] McLoughlin,"

Phrase: "D."
Processing 00000000.tx.312: M., and Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.313: C. 

Phrase: "C."
Processing 00000000.tx.314: J. 

Phrase: "J."
Processing 00000000.tx.315: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.316: 397, 197-200[CrossRef][Medline] [OrderarticleviaInfotrieve] Bressler, S. 

Phrase: "397,"

Phrase: "197-200"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bressler,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.317: L., Gray, M. 

Phrase: "L., Gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.318: D., Sopher, B. 

Phrase: "D."

Phrase: ","

Phrase: "Sopher,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.319: L., Hu, Q. 

Phrase: "L., Hu,"

Phrase: "Q."
Processing 00000000.tx.320: B., Hearn, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hearn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: G., Pham, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pham,"

Phrase: "D."
Processing 00000000.tx.322: G., Dinulos, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dinulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: B., Fukuchi, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fukuchi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.324: I., Sisodia, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.325: S., Miller, M. 

Phrase: "S."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: A., Disteche, C. 

Phrase: "A.,"

Phrase: "Disteche,"

Phrase: "C."
Processing 00000000.tx.327: M., and Martin, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.328: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: (1996) Hum. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.330: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.331: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.332: 5, 1589-1598[Abstract/Free FullText] Borg, J.-P., Ooi, J., Levy, E., and Margolis, B. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1589-1598"

Phrase: "[Abstract/Free FullText"

Phrase: "] Borg,"

Phrase: "J.-P.,"

Phrase: "Ooi,"

Phrase: "J.,"

Phrase: "Levy,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Margolis,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.333: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.334: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.335: Biol. 

Phrase: "Biol."
Processing 00000000.tx.336: 16, 6229-6241[Abstract] Gunette, S. 

Phrase: "16,"

Phrase: "6229-6241"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gunette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.337: Y., Chen, J., Jondro, P. 

Phrase: "Y.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.338: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.339: E. 

Phrase: "E."
Processing 00000000.tx.340: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.341: Natl. 

Phrase: "Natl."
Processing 00000000.tx.342: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.343: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.344: U. 

Phrase: "U."
Processing 00000000.tx.345: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.346: A. 

Phrase: "A."
Processing 00000000.tx.347: 93, 10832-10837[Abstract/Free FullText] Duilio, A., Faraonio, R., Minopoli, G., Zambrano, N., and Russo, T. 

Phrase: "93,"

Phrase: "10832-10837"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duilio,"

Phrase: "A.,"

Phrase: "Faraonio,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.348: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.349: J. 

Phrase: "J."
Processing 00000000.tx.350: 330, 513-519[Medline] [OrderarticleviaInfotrieve] Trommsdorff, M., Borg, J.-P., Margolis, B., and Herz, J. 

Phrase: "330,"

Phrase: "513-519"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Trommsdorff,"

Phrase: "M."

Phrase: ","

Phrase: "Borg,"

Phrase: "J.-P.,"

Phrase: "Margolis,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.351: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.354: 273, 33556-33560[Abstract/Free FullText] Tomita, S., Ozaki, T., Taru, H., Oguchi, S., Takeda, S., Yagi, Y., Sakiyama, S., Kirino, Y., and Suzuki, T. 

Phrase: "273,"

Phrase: "33556-33560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tomita,"

Phrase: "S."

Phrase: ","

Phrase: "Ozaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Oguchi,"

Phrase: "S."

Phrase: ","

Phrase: "Takeda,"

Phrase: "S."

Phrase: ","

Phrase: "Yagi,"

Phrase: "Y.,"

Phrase: "Sakiyama,"

Phrase: "S."

Phrase: ","

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.355: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.356: Biol. 

Phrase: "Biol."
Processing 00000000.tx.357: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.358: 274, 2243-2254[Abstract/Free FullText] Howell, B. 

Phrase: "274,"

Phrase: "2243-2254"

Phrase: "[Abstract/Free FullText"

Phrase: "] Howell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.359: W., Lanier, L. 

Phrase: "W., Lanier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.360: M., Frank, R., Gertler, F. 

Phrase: "M."

Phrase: ","

Phrase: "Frank,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gertler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.361: B., and Cooper, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.362: A. 

Phrase: "A."
Processing 00000000.tx.363: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.364: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.365: Biol. 

Phrase: "Biol."
Processing 00000000.tx.366: 19, 5179-5188[Abstract/Free FullText] Matsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hira, S., Ohno, S., Kita, Y., Kawasumi, M., Kouyama, K., Yamamoto, T., Kyriakis, J. 

Phrase: "19,"

Phrase: "5179-5188"

Phrase: "[Abstract/Free FullText"

Phrase: "] Matsuda,"

Phrase: "S."

Phrase: ","

Phrase: "Yasukawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Homma,"

Phrase: "Y.,"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "Y.,"

Phrase: "Niikura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hiraki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hira,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415549:HIRA [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Ohno,"

Phrase: "S."

Phrase: ","

Phrase: "Kita,"

Phrase: "Y.,"

Phrase: "Kawasumi,"

Phrase: "M."

Phrase: ","

Phrase: "Kouyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kyriakis,"

Phrase: "J."
Processing 00000000.tx.367: M., and Nishimoto, I. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.368: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.369: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.370: 21, 6597-6607[Abstract/Free FullText] Roncarati, R., Sestan, N., Scheinfeld, M. 

Phrase: "21,"

Phrase: "6597-6607"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roncarati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sestan,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: H., Berechid, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Berechid,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.372: E., Lopez, P. 

Phrase: "E.,"

Phrase: "Lopez,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.373: A., Meucci, O., McGlade, J. 

Phrase: "A.,"

Phrase: "Meucci,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "McGlade,"

Phrase: "J."
Processing 00000000.tx.374: C., Rakic, P., and D'Adamio, L. 

Phrase: "C., Rakic,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.375: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.376: Natl. 

Phrase: "Natl."
Processing 00000000.tx.377: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.378: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.379: U. 

Phrase: "U."
Processing 00000000.tx.380: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.381: A. 

Phrase: "A."
Processing 00000000.tx.382: 99, 7102-7107[Abstract/Free FullText] Scheinfeld, M. 

Phrase: "99,"

Phrase: "7102-7107"

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.383: H., Roncarati, R., Vito, P., Lopez, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roncarati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lopez,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.384: A., Abdallah, M., and D'Adamio, L. 

Phrase: "A.,"

Phrase: "Abdallah,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.385: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.386: Biol. 

Phrase: "Biol."
Processing 00000000.tx.387: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.388: 277, 3767-3775[Abstract/Free FullText] Tarr, P. 

Phrase: "277,"

Phrase: "3767-3775"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tarr,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.389: E., Roncarati, R., Pelicci, G., Pelicci, P. 

Phrase: "E.,"

Phrase: "Roncarati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pelicci,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pelicci,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.390: G., and D'Adamio, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.391: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.392: Biol. 

Phrase: "Biol."
Processing 00000000.tx.393: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.394: 277, 16798-16804[Abstract/Free FullText] Taru, H., Iijima, K., Hase, M., Kirino, Y., Yagi, Y., and Suzuki, T. 

Phrase: "277,"

Phrase: "16798-16804"

Phrase: "[Abstract/Free FullText"

Phrase: "] Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iijima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hase,"

Phrase: "M."

Phrase: ","

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "Yagi,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.395: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.396: Biol. 

Phrase: "Biol."
Processing 00000000.tx.397: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.398: 277, 20070-20078[Abstract/Free FullText] Homayouni, R., Rice, D. 

Phrase: "277,"

Phrase: "20070-20078"

Phrase: "[Abstract/Free FullText"

Phrase: "] Homayouni,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.399: S., Sheldon, M., and Curran, T. 

Phrase: "S."

Phrase: ","

Phrase: "Sheldon,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Curran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.400: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.401: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.402: 19, 7507-7515[Abstract/Free FullText] Baek, S. 

Phrase: "19,"

Phrase: "7507-7515"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baek,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.403: H., Ohgi, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohgi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.404: A., Rose, D. 

Phrase: "A.,"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.405: W., Koo, E. 

Phrase: "W., Koo,"

Phrase: "E."
Processing 00000000.tx.406: H., Glass, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.407: K., and Rosenfeld, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosenfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.408: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.409: (2002) Cell 110, 55-67[Medline] [OrderarticleviaInfotrieve] Gao, Y., and Pimplikar, S. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Cell 110,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "55-67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gao,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Pimplikar,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.410: W. 

Phrase: "W."
Processing 00000000.tx.411: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.412: Natl. 

Phrase: "Natl."
Processing 00000000.tx.413: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.414: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.415: U. 

Phrase: "U."
Processing 00000000.tx.416: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.417: A. 

Phrase: "A."
Processing 00000000.tx.418: 98, 14979-14984[Abstract/Free FullText] Cao, X., and Sdhof, T. 

Phrase: "98,"

Phrase: "14979-14984"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cao,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.419: C. 

Phrase: "C."
Processing 00000000.tx.420: (2001) Science 293, 115-120[Abstract/Free FullText] Cupers, P., Orlans, I., Craessaerts, K., Annaert, W., and De Strooper, B. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "115-120"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Orlans,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "and"

Phrase: "De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.421: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.422: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.423: 78, 1168-1178[CrossRef][Medline] [OrderarticleviaInfotrieve] Kimberly, W. 

Phrase: "78,"

Phrase: "1168-1178"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kimberly,"

Phrase: "W."
Processing 00000000.tx.424: T., Zheng, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "J."
Processing 00000000.tx.425: B., Guenette, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.426: Y., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.427: J. 

Phrase: "J."
Processing 00000000.tx.428: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Biol. 

Phrase: "Biol."
Processing 00000000.tx.430: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.431: 276, 40288-40292[Abstract/Free FullText] Kinoshita, A., Whelan, C. 

Phrase: "276,"

Phrase: "40288-40292"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinoshita,"

Phrase: "A.,"

Phrase: "Whelan,"

Phrase: "C."
Processing 00000000.tx.432: M., Smith, C. 

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.433: J., Berezovska, O., and Hyman, B. 

Phrase: "J.,"

Phrase: "Berezovska,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.434: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.435: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.437: 82, 839-847[CrossRef][Medline] [OrderarticleviaInfotrieve] Scheinfeld, M. 

Phrase: "82,"

Phrase: "839-847"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: H., Ghersi, E., Laky, K., Fowlkes, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ghersi,"

Phrase: "E.,"

Phrase: "Laky,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fowlkes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.439: J., and D'Adamio, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.440: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.441: Biol. 

Phrase: "Biol."
Processing 00000000.tx.442: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.443: 277, 44195-44201[Abstract/Free FullText] Walsh, D. 

Phrase: "277,"

Phrase: "44195-44201"

Phrase: "[Abstract/Free FullText"

Phrase: "] Walsh,"

Phrase: "D."
Processing 00000000.tx.444: M., Fadeeva, J. 

Phrase: "M."

Phrase: ","

Phrase: "Fadeeva,"

Phrase: "J."
Processing 00000000.tx.445: V., LaVoie, M. 

Phrase: "V., LaVoie,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.446: J., Paliga, K., Eggert, S., Kimberly, W. 

Phrase: "J.,"

Phrase: "Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3284170:Paliga [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eggert,"

Phrase: "S."

Phrase: ","

Phrase: "Kimberly,"

Phrase: "W."
Processing 00000000.tx.447: T., Wasco, W., and Selkoe, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.448: J. 

Phrase: "J."
Processing 00000000.tx.449: (2003) Biochemistry 42, 6664-6673[CrossRef][Medline] [OrderarticleviaInfotrieve] Zambrano, N., Minopoli, G., De Candia, P., and Russo, T. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "6664-6673"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "De Candia,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.450: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.451: Biol. 

Phrase: "Biol."
Processing 00000000.tx.452: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.453: 273, 20128-20133[Abstract/Free FullText] Ermekova, K. 

Phrase: "273,"

Phrase: "20128-20133"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ermekova,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.454: S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., and Sudol, M. 

Phrase: "S."

Phrase: ","

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Linn,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gertler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Russo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sudol,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.456: Biol. 

Phrase: "Biol."
Processing 00000000.tx.457: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.458: 272, 32869-32877[Abstract/Free FullText] Zambrano, N., Bruni, P., Minopoli, G., Mosca, R., Molino, D., Russo, C., Schettini, G., Sudol, M., and Russo, T. 

Phrase: "272,"

Phrase: "32869-32877"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mosca,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Molino,"

Phrase: "D."

Phrase: ","

Phrase: "Russo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schettini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sudol,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.459: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.460: Biol. 

Phrase: "Biol."
Processing 00000000.tx.461: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.462: 276, 19787-19792[Abstract/Free FullText] Minopoli, G., De Candia, P., Bonetti, A., Faraonio, R., Zambrano, N., and Russo, T. 

Phrase: "276,"

Phrase: "19787-19792"

Phrase: "[Abstract/Free FullText"

Phrase: "] Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "De Candia,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bonetti,"

Phrase: "A.,"

Phrase: "Faraonio,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.463: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.464: Biol. 

Phrase: "Biol."
Processing 00000000.tx.465: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.466: 276, 6545-6550[Abstract/Free FullText] Shaul, Y. 

Phrase: "276,"

Phrase: "6545-6550"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shaul,"

Phrase: "Y."
Processing 00000000.tx.467: (2000) Cell Death Diff. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cell Death Diff."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0007587:Cell Death [Cell Function]
Processing 00000000.tx.468: 7, 10-16[CrossRef][Medline] [OrderarticleviaInfotrieve] Van Etten, R. 

Phrase: "7,"

Phrase: "10-16"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Van Etten,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.469: A. 

Phrase: "A."
Processing 00000000.tx.470: (1999) Trends Cell Biol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.471: 9, 179-186[CrossRef][Medline] [OrderarticleviaInfotrieve] McLoughlin, D. 

Phrase: "9,"

Phrase: "179-186"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McLoughlin,"

Phrase: "D."
Processing 00000000.tx.472: M., Irving, N. 

Phrase: "M."

Phrase: ","

Phrase: "Irving,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.473: G., Brownlees, J., Brion, J.-P., Leroy, K., and Miller, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brownlees,"

Phrase: "J.,"

Phrase: "Brion,"

Phrase: "J.-P.,"

Phrase: "Leroy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.474: C. 

Phrase: "C."
Processing 00000000.tx.475: J. 

Phrase: "J."
Processing 00000000.tx.476: (1999) Eur. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.477: J. 

Phrase: "J."
Processing 00000000.tx.478: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.479: 11, 1988-1994[CrossRef][Medline] [OrderarticleviaInfotrieve] Lau, K.-F., McLoughlin, D. 

Phrase: "11,"

Phrase: "1988-1994"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lau,"

Phrase: "K.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McLoughlin,"

Phrase: "D."
Processing 00000000.tx.480: M., Standen, C. 

Phrase: "M."

Phrase: ","

Phrase: "Standen,"

Phrase: "C."
Processing 00000000.tx.481: L., Irving, N. 

Phrase: "L., Irving,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.482: G., and Miller, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.483: C. 

Phrase: "C."
Processing 00000000.tx.484: J. 

Phrase: "J."
Processing 00000000.tx.485: (2000) NeuroReports 16, 3607-3610 Zukerberg, L. 

Phrase: "(2000"

Phrase: ")"

Phrase: "NeuroReports 16,"

Phrase: "3607-3610 Zukerberg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.486: R., Patrick, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Patrick,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.487: N., Nikolic, M., Humbert, S., Wu, C. 

Phrase: "N., Nikolic,"

Phrase: "M."

Phrase: ","

Phrase: "Humbert,"

Phrase: "S."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C."
Processing 00000000.tx.488: L., Lanier, L. 

Phrase: "L., Lanier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.489: M., Gertler, F. 

Phrase: "M."

Phrase: ","

Phrase: "Gertler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.490: B., Vidal, M., Van Etten, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "M."

Phrase: ","

Phrase: "Van Etten,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.491: A., and Tsai, L.-H. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Tsai,"

Phrase: "L.-H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.492: (2000) Neuron 26, 633-646[Medline] [OrderarticleviaInfotrieve] Gu, Y. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuron 26,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "633-646"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gu,"

Phrase: "Y."
Processing 00000000.tx.493: J., Misonou, H., Sato, T., Dohmae, N., Takio, K., and Ihara, Y. 

Phrase: "J.,"

Phrase: "Misonou,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sato,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dohmae,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.494: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.495: Biol. 

Phrase: "Biol."
Processing 00000000.tx.496: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.497: 276, 35235-35238[Abstract/Free FullText] Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M. 

Phrase: "276,"

Phrase: "35235-35238"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sastre,"

Phrase: "M."

Phrase: ","

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fuchs,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.498: M., Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.499: B., and Haass, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.500: (2001) EMBO Rep. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.501: 2, 835-841[Abstract/Free FullText] Weidemann, A., Eggert, S., Reinhard, F. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "835-841"

Phrase: "[Abstract/Free FullText"

Phrase: "] Weidemann,"

Phrase: "A.,"

Phrase: "Eggert,"

Phrase: "S."

Phrase: ","

Phrase: "Reinhard,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.502: B., Vogel, M., Paliga, K., Baier, G., Masters, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vogel,"

Phrase: "M."

Phrase: ","

Phrase: "Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3284170:Paliga [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Baier,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.503: L., Beyreuther, K., and Evin, G. 

Phrase: "L., Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Evin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.504: (2002) Biochemistry 41, 2825-3285[CrossRef][Medline] [OrderarticleviaInfotrieve] Sadowski, I., Bell, B., Broad, P., and Hollis, M. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemistry 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2825-3285"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sadowski,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Broad,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332464:Broad [Spatial Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hollis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1256218:hollis [Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.505: (1992) Gene (Amst.) 

Phrase: "(1992"

Phrase: ")"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(Amst."

Phrase: ")"
Processing 00000000.tx.506: 118, 137-141[CrossRef][Medline] [OrderarticleviaInfotrieve] Gianni, D., Zambrano, N., Bimonte, M., Minopoli, G., Mercken, L., Talamo, F., Scaloni, A., and Russo, T. 

Phrase: "118,"

Phrase: "137-141"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gianni,"

Phrase: "D."

Phrase: ","

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bimonte,"

Phrase: "M."

Phrase: ","

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Talamo,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Scaloni,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.507: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.510: 278, 9290-9297[Abstract/Free FullText] Lau, K.-F., McLoughlin, D. 

Phrase: "278,"

Phrase: "9290-9297"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lau,"

Phrase: "K.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McLoughlin,"

Phrase: "D."
Processing 00000000.tx.511: M., Standen, C., and Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "Standen,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.512: C. 

Phrase: "C."
Processing 00000000.tx.513: J. 

Phrase: "J."
Processing 00000000.tx.514: (2000) Mol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.515: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.516: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.517: 16, 555-563 Kesavapany, S., Banner, S. 

Phrase: "16,"

Phrase: "555-563 Kesavapany,"

Phrase: "S."

Phrase: ","

Phrase: "Banner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273749:Banner [Organic Chemical,Pharmacologic Substance]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.518: J., Lau, K. 

Phrase: "J.,"

Phrase: "Lau,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.519: F., Shaw, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shaw,"

Phrase: "C."
Processing 00000000.tx.520: E., Miller, C. 

Phrase: "E.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.521: C., Cooper, J. 

Phrase: "C., Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.522: D., and McLoughlin, D. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "McLoughlin,"

Phrase: "D."
Processing 00000000.tx.523: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.524: (2002) Neuroscience 115, 951-960[CrossRef][Medline] [OrderarticleviaInfotrieve] McLoughlin, D. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuroscience 115,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "951-960"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McLoughlin,"

Phrase: "D."
Processing 00000000.tx.525: M., Standen, C. 

Phrase: "M."

Phrase: ","

Phrase: "Standen,"

Phrase: "C."
Processing 00000000.tx.526: L., Lau, K.-F., Ackerley, S., Bartnikas, T. 

Phrase: "L., Lau,"

Phrase: "K.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ackerley,"

Phrase: "S."

Phrase: ","

Phrase: "Bartnikas,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.527: P., Gitlin, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gitlin,"

Phrase: "J."
Processing 00000000.tx.528: D., and Miller, C. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.529: C. 

Phrase: "C."
Processing 00000000.tx.530: J. 

Phrase: "J."
Processing 00000000.tx.531: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.532: Biol. 

Phrase: "Biol."
Processing 00000000.tx.533: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.534: 276, 9303-9307[Abstract/Free FullText] Standen, C. 

Phrase: "276,"

Phrase: "9303-9307"

Phrase: "[Abstract/Free FullText"

Phrase: "] Standen,"

Phrase: "C."
Processing 00000000.tx.535: L., Perkinton, M. 

Phrase: "L., Perkinton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.536: S., Byers, H. 

Phrase: "S."

Phrase: ","

Phrase: "Byers,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.537: L., Kesavapany, S., Lau, K. 

Phrase: "L., Kesavapany,"

Phrase: "S."

Phrase: ","

Phrase: "Lau,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.538: F., Ward, M., McLoughlin, D., and Miller, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "McLoughlin,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.539: C. 

Phrase: "C."
Processing 00000000.tx.540: (2003) Mol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.541: Cell Neurosci. 

Phrase: "Cell Neurosci."
Processing 00000000.tx.542: 24, 851-857[CrossRef][Medline] [OrderarticleviaInfotrieve] Scheinfeld, M. 

Phrase: "24,"

Phrase: "851-857"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: H., Matsuda, S., and D'Adamio, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsuda,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.544: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.545: Natl. 

Phrase: "Natl."
Processing 00000000.tx.546: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.547: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.548: U. 

Phrase: "U."
Processing 00000000.tx.549: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.550: A. 

Phrase: "A."
Processing 00000000.tx.551: 100, 1729-1734[Abstract/Free FullText] Kim, H. 

Phrase: "100,"

Phrase: "1729-1734"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.552: S., Kim, E. 

Phrase: "S."

Phrase: ","

Phrase: "Kim,"

Phrase: "E."
Processing 00000000.tx.553: M., Lee, J. 

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.554: P., Park, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.555: H., Kim, S., Seo, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Seo,"

Phrase: "J."
Processing 00000000.tx.556: H., Chang, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.557: A., Yu, E., Jeong, S. 

Phrase: "A.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "E.,"

Phrase: "Jeong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.558: J., Chong, Y. 

Phrase: "J.,"

Phrase: "Chong,"

Phrase: "Y."
Processing 00000000.tx.559: H., and Suh, Y. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.560: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.561: (2003) FASEB J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.562: 17, 1951-1953[Abstract/Free FullText] Kinoshita, A., Whelan, C. 

Phrase: "17,"

Phrase: "1951-1953"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinoshita,"

Phrase: "A.,"

Phrase: "Whelan,"

Phrase: "C."
Processing 00000000.tx.563: M., Berezovska, O., and Hyman, B. 

Phrase: "M."

Phrase: ","

Phrase: "Berezovska,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.564: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.565: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.566: Biol. 

Phrase: "Biol."
Processing 00000000.tx.567: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.568: 277, 28530-28536[Abstract/Free FullText] Biederer, T., Cao, X., Sudhof, T. 

Phrase: "277,"

Phrase: "28530-28536"

Phrase: "[Abstract/Free FullText"

Phrase: "] Biederer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cao,"

Phrase: "X.,"

Phrase: "Sudhof,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.569: C., and Liu, X. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Liu,"

Phrase: "X."
Processing 00000000.tx.570: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.571: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.572: 22, 7340-7351[Abstract/Free FullText] Russo, C., Dolcini, V., Salis, S., Venezia, V., Violani, E., Carlo, P., Zambrano, N., Russo, T., and Schettini, G. 

Phrase: "22,"

Phrase: "7340-7351"

Phrase: "[Abstract/Free FullText"

Phrase: "] Russo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Dolcini,"

Phrase: "V.,"

Phrase: "Salis,"

Phrase: "S."

Phrase: ","

Phrase: "Venezia,"

Phrase: "V.,"

Phrase: "Violani,"

Phrase: "E.,"

Phrase: "Carlo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445462:carlo [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Russo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Schettini,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.573: (2002) Ann. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.574: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.575: Y. 

Phrase: "Y."
Processing 00000000.tx.576: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.577: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.578: 973, 323-333[Abstract/Free FullText] Robakis, N. 

Phrase: "973,"

Phrase: "323-333"

Phrase: "[Abstract/Free FullText"

Phrase: "] Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.579: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.580: (2003) Amyloid 10, 80-85[Medline] [OrderarticleviaInfotrieve] Marambaud, P., Wen, P. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Amyloid 10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "80-85"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.581: H., Dutt, A., Shioi, J., Takashima, A., Siman, R., and Robakis, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dutt,"

Phrase: "A.,"

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.582: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.583: (2003) Cell 114, 635-645 Roepstorff, P., and Fohlman, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Cell 114,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "635-645 Roepstorff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Fohlman,"

Phrase: "J."
Processing 00000000.tx.584: (1984) Biomed. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biomed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332030:Biomed [Health Care Related Organization]
Processing 00000000.tx.585: Mass Spectrom. 

Phrase: "Mass Spectrom."
Processing 00000000.tx.586: 11, 601[Medline] [OrderarticleviaInfotrieve]

Phrase: "11,"

Phrase: "601"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

